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Abstract

The focus of this research is on base modified nucleosides. By generating these
nucleosides we hope to find information about the role of “base-stacking” in the
stability of the DNA duplex and generate nucleoside analogues that could be used as
conversion agents or in ambiguous positions in probes and primers. The target
nucleosides included one C-nucleoside 5-(2'-deoxy-p-D-ribofuranosyl)-2hydroxypyrimidine and four 4-substituted pyrazole nucleosides; l-(2'-deoxy-P-Dribofiiranosyl)-4-iodopyrazole, l-(2’-deoxy-P-D-ribofiiranosyl)-4-, l-(2'-deoxy-P-Dribofinanosyl)-4-propynylpyrazole, and l-(2'-deoxy-P-D-ribofuranosyl)-4-(2thiazolyl)pyrazole.
The C-nucleoside was of interest because of its potential anti-viral and anti
cancer activity and its potential to fimction as a “convertide”. There are several
potential routes for the synthesis of C-nucleosides. The two routes we attempted were
based on a palladiimi catalyzed Heck type coupling and a Grignard reaction. Neither
route was successful. The palladium coupling was hindered mostly by the poorly
defined reaction conditions and the complex mix of product produced. It was initially
hampered by the difiBculty in obtaining the requisite glycals for the reaction. This
problem; however, was addressed by generating protected glycals by the treatment of
appropriately protected thymidines with hexamethyldisilazane. The Grignard coupling
route produced mostly addition of the base to the toluoyl protecting group. In addition
both methods may have been hindered by acid lability of the base.

XV
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The pyrazole nucleosides were easily synthesized by addition of the sodium salt
of the base to a p-toluoyl protected 1-chlororibose. The pyrazole nucleosides were then
converted to the phosphoramidites and incorporated into oligonucleotides using
standard solid phase coupling conditions. Once incorporated into oligonucleotides the
relative stabilities of the nucleosides were measured by thermodynamic melting.
Overall the thiazolylpyrazole nucleoside was the most stable and the iodopyrazole was
the least stable. The propynylpyrazole and the nhropyrazole were similar. All four
nucleosides showed a preference for the purines and were lease stable versus dC. The
nucleosides were also found to function in PCR reactions. The initial preference for the
natural nucleoside incorporated versus each modified nucleoside was a dC; however,
this is most likely a result of impure starting materials.

XVI

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Chapter 1
Introduction

The existence o f DNA (deoxyribose nucleic acids) was first discovered in 1868
by Friedrich Miescher^ Wio isolated phosphorus containing compounds which he called
'nuclein' from pus in discarded surgical bandages. It was not until the nineteen fifties,
however, that the primary structure of the nucleotides was established through work
done by Todd and coworkers^ and Cohn and cowodcers.^ Then, following the woric of
several of their contemporaries,^^ Watson and Crick^O proposed the double helix
secondary structure made of specifically hydrogen bonding pairs Since that discovery
there has been an explosion of research on the molecule that is the genetic blueprint of
all living things.^ ^
1.1 Statement of Proposal
The focus o f this research is on base modified nucleosides. By generating these
nucleosides we hope to find information about the role of base stacking in the stability
of the DNA duplex. In addition the nucleoside analogues could be used as conversion
agents or in ambiguous positions in probes and primers. Conversion agents refers to the
use of a nucleoside to change a complementary base from one to another during the
polymerase chain reaction (PCR). However for this to be accomplished the bases must
function in PCR. Therefore several nucleosides were designed and tested for stability in
a duplex by thermal melting and in PCR reactions. The first is 5-(2'-deoxy-P-Dribofuranosyl)-2-hydroxypyrimidine (Figure 1.1, A). The nucleoside was designed to

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Figure 1.1 Target nucleosides
function as a conversion agent by “reading” an “A or G” and “writing” an “A”. This is
accomplished by making use of the tautomerization of the nucleoside which changes its
pairing selectivity for the natural nucleosides. In addition this nucleoside is a Cnucleoside which is of interest in its own right because of the potential for anti-viral and
anti-cancer properties. The other nucleosides are designed to illuminate the differences
that charge distribution, polarizability, and size of the heteroaromatic ring have on base
stacking in the double helix. These nucleosides are non-hydrogen bonding 4-substitued
pyrazoles, l-(2'-deoxy-P-D-ribofuranosyl)-4-iodopyrazole (Figure 1.1, B),
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l-(2’-deoxy-P-D-ribofuranosyl)-4-nitropyrazoIe (Figure 1.1, C), l-(2'-deoxy-P-Dribofiiranosyl)-4-propynylpyrazole (Figure 1.1, D), and l-(2'-deoxy-P-D-ribofiiranosyl)4-(2-thiazolyl)pyrazole (Figure 1.1, E).12
1Jt Primaiy Structure of DNA
DNA is composed of strands of purine (A,G) and pyrimidine (T,C) bases
connected by sugar-phosphate backbones. There are four common, naturally occurring
bases in DNA, adenine and guanine (the purines) and thymidine and cytosine (the
pyrimidines). When these are attached to the sugar portion (2-deoxyribose in the Dfuranose form) they are called nucleosides (Figure 1.2). The nucleosides are connected
to one another by a phosphodiester linkage of the 3'-hydroxyl of one nucleoside to the
5'-hydroxyl of another (Figure 1.3). This arrangement gives an overall polarity to the

HO

HO

OH

OH

Thymidine (T)

Cytidine (C)

NH
HO

HO

G uanine (G)

Adenosine (A)

Figure 1,2 Structure of the natural nucleosides
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nucleic acid. One end of the chain bears a 5' phosphate group whereas the other end
bears a 3' hydroxyl.

W

NHz

O^P^-O-

% °v

o

Figure 13 Structure of an oligonucleotide (S'-TCGA-3')
13 Secondary Structure of DNA
Two of the single strands of DNA described above are hydrogen bound together
through their bases. They are in an antiparallel right handed helix that has the same axis
for both polynucleotide chains. The hydrogen bonding occurs almost exclusively as
adenine(A) pairing to thymidine (T) and cytidine (C) pairing to guanine (G)(Figure 1.4).
This is the Watson-Crick arrangement It is therefore obvious that the sequence of one
strand dictates the sequence of its complement. The bases of each strand are stacked on
top of each other making the duplex resemble a ladder. Even indien bases lack a pairing
partner the bases still stack in the h e l i x .
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H
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Figure 1.4 Watson-Crick hydrogen bonding of nucleosides
The stability of the duplex is derived from three sources in-plane (hydrogen
bonding), out-of-plane (base stacking) and the interaction of hydrophobic bases with
water. The hydrogen bonding is rather self-evident The base stacking occurs because
the purines and pyrimidines are attracted to each other. At a spacing of 0.36 nm for two
parallel rings you have optimum interaction of the clouds of tcelectron clouds that lie on
either side of the rings. Oligonucleotides are composed of a hydrophilic sugar
phosphate backbone which is able to hydrogen bond well with the water and
hydrophobic bases which do not. Therefore the bases tend to aggregate in the center
surrounded by the backbone.
1.4 Synthesis of Modified Nucleosides
The original chemical synthesis o f nucleosides was to prove their structures. It was
found that it was more economical to produce the nucleosides by degradation of nucleic
acids rather than by total synthesis even with advances in stereospecifrc synthesis.
Chemical synthesis however is often the route of choice for the production of modified
nucleosides vdiich are useful as metabolism inhibitors, as well as anti-cancer and anti
viral drugs.
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There have been a number of modified nucleosides and oligonucleotides
prepared for a variety o f reasons. They have been prepared to study the interactions of
base pairs in double helices, for anti-viral or anti-cancer properties, and to study proteinDNA interaction to name a few uses. Every section of the nucleotide has been the
subject of modification. Examples include the sugar portion being changed to be
acyclicl^>15 (Figure 1.5, path A) the interaucleotide linkage being changed to
phosphorthioates ^^ (Figure 1.5, path B) and phosphordithioates^ ^ (Figure 1.5, path C)
or the phosphorus being completely replaced!^ (Figure 1.5, path D) and there have been
numerous modifications to the bases. The base portion of the nucleotides have been
changed to everything fix>m an abasic site or a simple phenyl rmg,^^’^® to slight
modifications of natural bases such as

7 - d e a z a - 2 ’ d e o x y a d e n o s i n e 2 1 » 2 2

jq completely

original multiring systems such as the anthracenyl deoxyguanosine phosphoramidite.^^
There have been literally hundreds of base modified nucleosides prepared and reviews
that include discussions of them are extensive and p l e n t i f u l . 2 4 - 2 7
1.4.1 Non-Hydrogen Bonding Nucleoside Analogues
The first appearance of non-hydrogen bonding base modified nucleosides was with
abasic s i t e s

(Figure

1 .6 ,1 )

or a phenyl g r o u p ^ O (Figure

1 .6 ,2 ) .

Neither of these

were very stable but the abasic site was more stable than the phenyl. One of the first
non-hydrogen bonding analogs that possessed some degree of stability (based on Tm)
was 3-nitropyrrole (Figure 1.6,3) synthesized by Bergstrom et

This molecule

was designed to be small enough to be incorporated versus purines without disrupting
H-bonding and to mimic the electronic configuration ofp-nitroaniline, a known DNA
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intercolator. 3-Nitropyrrole is a relatively universal nucleoside, having a

range

of only 3*’C for pairing versus the four natural nucleosides, however, it does show a
preference for the purines, A in particular. Interestingly, even without any hydrogen
bonding c^)abilities it was shown to be a fairly stable modified nucleoside more so even
than deoxyinosine^ 1 although it did have a general destabilizing (lower Tm) effect over
the fully complementary DNA duplexes. The idea of non-hydrogen nucleosides was
followed in the same vein by Brown and Loakes with 4-, 5- and 6-nitroindole^^ (Figure
1.6,4). 5-Nitroindole was found to be the least destabilizing (about 5®C), better even
then 3-nitropyrrole and it also showed a ATm of 3°C when it was paired with each of the
natural nucleosides. With all of the nitroindoles, the preference was for pairing with dC.
Kool and co-workers approached the problem from a different angle, instead of
incorporating heterocycles that mimicked intercolators they synthesized non-hydrogen
bonding bases that were isosteric and isoelectronic with the natural purines and
p y r im id in e s .3 3

Two of the compounds were mimics of dT, diflourotoluene (Figure 1.6,

5) and trimethylbenzene (Figure 1.6,6), the third was a mimic of dA, dimethylindole
(Figure 1.6, 7). They found a single incorporation across 6om a natural nucleoside
lowered the Tm of the duplex ~ 20®C but incorporation of pairs of non-hydrogen
bonding nucleosides was less destabilizing. For example the Tm o f the control
dodecamer with a T-A pair in the position of interest was 39.4 ®C. When the thymidine
was changed to diflourotoluene the Tm dropped to 21.4 °C. However when both the
thymidine and adenine were replaced by diflourotoluene the Tm dropped only to
28.6 ®C. Following the work of Turner and c o w o r k e r s , 3 4 they placed a series of
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modified nucleosides in a dangling position o f a duplex to determine the effect on
stability. The series o f nucleosides ranged in size and polarity and were put on the end
of a DNA duplex in a position that had no pair. They found that the nucleoside analogs
that were larger and less polar increased the Tm the most.
Bergstrom et

investigated the stability of non-hydrogen bases by

incorporating a series o f nitro substituted azoles as well as some non-nitro containing
controls into an olignucleotide. Thty discovered that the role of the nitro group was
extremely important in stabilization. They also discovered that a ring nitrogen capable
of hydrogen bonding decreased the “universality” of the nucleoside.
Froehler et

found that substituting a propyne substituent onto the C-5

position of cytidine (Figure 1.6,8) and uridine increased the stability because of
entropie factors caused by the hydrophobic chain displacing water. In addition the
propynyl unit probably allows increased stacking. Froehler et al.^^ also found that a
thiazole substituent on the C-5 position increased the stability of a dC (Figure 1.6, 9) or
a dG. The thiazoyl substituent was postulated to be planar with the heterocycle which
allows a larger area o f delocalized n electrons which would aid in base stacking.
The design o f the 4-substituted pyrazole nucleosides (Figure 1.1, B-E) was
chosen because utilizing a small ring size would decrease the likelihood of steric
hindrance when placed versus one of the p u r i n e s . 2 9 The use of nitro, propyne and
thiazole substituents was chosen to lend added stability as well as allow a progression of
substituents that varies the electronic charge distribution profiles to determine their
effect on stability.
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1.4^ C-Nncleoside Analogues
The synthesis of C-nucieosides has been more limited because of the increased
difficulty of creating the C-C bond over the C-N bond. However, several approaches
have been developed for the preparation of C-nucleosides.^^’^^’^ ^ "^ This has allowed
the production of a wide range of C-nucleosides including natural nucleoside mimics
such as pseudouridine.^5"^^ An extensive review of C-nucleosides was prepared by
Watanabe.24
Daves et

have developed a method for the production of C-nucleosides

which utilizes a Pd-catalyzed Heck-type coupling o f aryl-halides to cyclic enol ethers.
This method which is an extension of work performed by Ireland et

was the

method chosen for the synthesis of 5-(2'-deoxy-P-D-ribofiiranosyl)-2-hydroxypyrimidine
(Figure 1.1, A)
1.5
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Chapter 2

Facile Preparatfon of Protected Paranoid Glycals from Thymidine*

2.1 Introduction
The preparation of aryl C-glycosides and C-nucleosides is of intense interest
because of their potential anti-viral and anti-tumor activity^ ^ and their use as novel
base pairing moieties in oligonucleotides.^'^ Several approaches have been developed
for the preparation o f C-glycosides and C-nucleosides including multi-step assembly of
the aryl unit de novo on the sugar moiety (Scheme 2.1, path A),^ multi-step assembly

Ar

(R'O)n

M

, 1]
(R'0 )„

(RO)n

T i.
(R'O) n

IIP

a

-

(R 'O )n

?

(R’O)n

Scheme 2.1 Strategies for the synthesis of C-nncleosides
of the sugar de novo on the aromatic aglycon (Scheme 2.1, path B),^ electrophilic
aromatic substitution with a glycosyl cation (Scheme 2.1, path C),^0 and nucleophilic
*Reproduced with permission ftom J. Org. Chem. 1997,62, 9065-9069.
Copyright 1997 American Chemical Society
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attack of aiyl organometallics directly onto lactones (Scheme 2.1, path

^ or

glycosyl halides (Scheme 2.1, path E).3-6 An alternative strategy for preparation of
C-nucleosides has been developed by Daves et a i 12-18 which utilizes a Pd-catalyzed
Heck-type coupling of aryl-halides to cyclic enol ethers, either pyranoid or furanoid
glycals (Scheme 2.1, path F).
A limitation o f this latter approach has been poor accessibility of the furanoid
glycals, which in contrast to pyranose glycals are highly acid labile. For example,
reduction of pyranosyl halides by elemental zinc in acetic acid produces good yields of
pyranose glycals;

this method fails for furanosyl g l y c a l s . 2 0 Ireland et al. 2 1

demonstrated a synthesis of 5-O-protected glycals in four steps from 2,3-isopropylidine
protected ribonolactone. The overall yield was 60%, but the 5-O-protection possibilities
were limited and scale up was difScult because of the aluminum hydride reduction,
chlorination, and dissolving metal reduction required in this route. A modified
approach was developed by Daves et al. ^2 to allow for differential protection of the 3and 5-hydroxyl groups. The method required six steps with an overall yield of 25%.
The protecting group choices were increased to include silyl protecting groups, but the
chemistry was still limited because of the need for DEBAl-H reduction, chlorination, and
Na/NH] reduction. More recently, two groups have developed methods to prepare
glycals firom 2-deoxyribose. Kassou and Castill6n23 have used a selenoxide
elimination approach to access glycals (3-5 steps, 40-65% yield) that is compatible with
3- and 5-acyl protection. Townsend and coworicers24 utilized the elimination of a 1-0mesylate on a protected 2-deo3tyribose to prepare mono- or bis-silyl-protected glycals
(4-5 steps, 20-82% yields).
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Pedersen et al. 25 reported that fiiranose erythro-^ycAs can be produced easily
from free thymidine or 5'-0-(/err-butyldiphenylsilyI)thymidine (Ic) by using typical
base silylation conditions; refluxing 1,1,1 ^^,3-hexamethyldisilazane (HMDS), and
(NH4)2S04 (Eq. 3.1). This approach has the advantage of readily available starting

R O -1 _ N '^ O HMDS, (NH,kSO«

w

—

R 0 -] n

— —

►

OR'
la-o

<’ )
OR'
2a-o

Eqaation 2.1 Conversion of protected thymidines to glycals
materials, potential compatibility with a wide range of protecting groups, and very
straightforward experimental procedures. Thus, we envisioned this as an ideal method
for making up to gram amounts of glycals rapidly and efficiently, as it avoids the
experimental difrculties of previous glycal preparations (e.g., large scale dissolving
metal reductions,2i,22 large scale aluminum hydride reductions^i-23) Herein we
show that this method works very well for preparation of fiiranose glycals with a wide
range of O-silyl protection. Additionally, 5-O-acyl protected glycals, previously only
accessible by a selenoxide elimination m

e th o d ,2 3

can also be prepared in good to

excellent yields with this straightforward chemistry.
2.2 Synthesis of Protected Thymidines
Protected thymidines la-o were prepared according to known procedures in one
(Ib -^ , two (Ih-m) or at most three (In-o) steps (Scheme 2.2 and Experimental). The

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

18

protection groups on the thymidines were introduced by silylation with either /errbutyldimethylsilylchloride (TBDMSCi) or /err-butyldiphenylsilylchloride (TBDPSCl)
and imidazole in DMF or by toluoylation with p-toluoylchloride in pyridine. Where

\J
OTd
liRpTBDMS
1kR>TBDPS

p-TolCI
_ pyr.

r

y

TBOMS-CI
or
JB D P S ^ I
imidazole

OR*
1b I^TBOMS, R*«H
1c R-TBDPS, R>H
1e R>TBOMS, IT-TBDMS
I f RbTBDPS, fTsTBDPS

la

p-TolCI ToK)
pyr.

-w

TBDMS-CI
or
TolO
TBDPS-CI
Imidazole

OR
1aR=H
1gR»Tol

OR
IIRsTBDMS
1m R=TBDPS

NH3
CH3OH

1

TBOMS-CI
O f

TBDPS-CI
imidazole
OR'
In RVTBDUS
1oR>TBOPS

OR"
1h R>TBDMS. R"=TBDPS
1j R-TBDPS, R"=TBOMS

Scheme 2J2 Synthesis of variously protected thymidines
5'-toIuoyl groups were used as temporary protection, they were removed by treatment
with ammonia in methanol.
2 3 Conversion to Glycals
On -0.2-3 mmol scales, the thymidines were treated under Pedersen's conditions
(Equation 2.1) and all, except for the 3'-0-toluoyl protected thymidines (lg,li,lk),
were converted to the corresponding protected glycals (Table 2.1). In the cases where a
free hydroxyl group was present (2b-2d, 2n, 2o), the initial product formed (according
to NMR) was the O-trimethylsilyl (TMS) derivative. Using standard work-up
conditions, the TMS group was cleaved and the free hydroxyl compound was isolated.
For optimal glycal yields, heating should be discontinued as soon as all the nucleoside is
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Table 2.1 Product yields for glycals

thymidine

glycal

R

R’

Yield (%)6.c Yield (% )
from la^

la

2a«

H

H

80

80(1)

lb

2be

TBDMS

H

74

53(2)

Ic

2c«

TBDPS

H

91

70(2)

Id

2d

Toi

H

52

38(2)

le

2e«

TBDMS

TBDMS

69

47(2)

If

2fe

TBDPS

TBDPS

80

76(2)

Ig

2g

Toi

Toi

a

a

Ih

2h

TBDMS

TBDPS

79

55(3)

li

2i

TBDMS

Toi

a

a

Ij

2j

TBDPS

TBDMS

59

40(3)

Ik

2k

TBDPS

Toi

a

a

11

21

Toi

TBDMS

74

39(3)

Im

2m

Toi

TBDPS

94

64(3)

In

2n

H

TBDMS

36

18(4)

53(4)
2o
lo
H
79
TBDPS
glycal product obtained. ^ Isolated yield after chromatography. ^ Purified silylprotected glycals decompose readily at room temperature, though they may be stored in
the freezer up to several weeks. In contrast, the 5-O-toluoyl glycals (2d, 21,2m) are
stable at room temperature for several days and appear to be indefinetely stable in the
fieezer. ^ The number in parentheses indicates the number of steps required to prepare
the glycal 6 om commercially available free thymidine la . ^ A separate time course
experiment was run to determine the rate of glycal formation for several o f the protected
thymidines: Thymidine (la-lc, le. If; 0.1 mmol), (NH4)2S04 (0.5 g, 3.8 mmol) in
HMDS (5 mL). Reaction mixtures were lowered simultaneously into preheated oil
baths and all started refluxing within 30 s. Disappearance of starting material (TLC,
GC) was considered as the end of the reaction. Reaction times: 2a, 170 min.; 2b, 125
min.; 2c, 145 min.; 2e, 180 min.; 2f, 180 min.
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consumed (TLC). In general, the crude products 6 om extraction are pure enough for
further reactions, though we report here yields after flash chromatographic purification
(Table 2.1).
23.1 Discussion
Yields of glycal products with O-TBDMS protection were always lower than
analogous TBDPS derivatives [e.g., 2b (74%) vs. 2c (91%); 2e (69%), 2j (59%) vs. 2f
(80%); 21 (74%) vs. 2m (94%); 2n (36%) vs. 2o (79%)]. This suggests some cleavage
of TBDMS ethers under the slightly acidic conditions of the reaction or overall lower
stability of the TBDMS glycals. As previously noted by P e d e r s e n , 2 5 thymidines in
which a 3'-ester group was included (Ig, li, Ik) produced no isolable glycal products
though starting material was consumed slowly^^ to form furfuryl alcohol d e r i v a t i v e s . ^ ^
The 5 -0-toluoyl-thymidines (Id, II, Im) were successfully converted to the
corresponding glycals and were found to be much more stable to storage than those with
only silyl protection (Table 2.1, foomote c).
2 3 3 Proposed Mechanism
The mechanism proposed by Pedersen et al. is consistent with these results. The
base is first silylated to give 3 (Scheme 2.3) which imdergoes an elimination to give
the intermediate oxonium ion 4 and then the glycal 1. The thymidines with toluoyl
groups on the 3 -0 yield no glycals because the ester acts as a leaving group that could
allow for the formation o f fiirfuryl alcohol (Scheme 2.3).
2.4 Conclusions
Using Pedersen's method, we have prepared furanoid glycals having both O-silyl
and, for the first time, 5-O-acyl protection. The advantages of this method are the
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Scheme 2 3 Proposed mechanism of glycal and fiirfuryl alcohol formation
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greater generality of protecting groups that can be used and the speed and experimental
ease with which glycals can be made. Previous methods for preparing fiiranose glycals
starting from ribonolactone require at least six steps and are difGcult to scale up because
of the required sequential DIBAl-H reduction, low temperature chlorination, and
Na/NH] reduction. The more recent approaches to glycals from 2 - d e o x y r i b o s e ^ 3 , 2 4 are
much improved, but still have some disadvantages relative to the Pedersen route from
thymidine. The Castillon method requires use of the toxic, pungent, and expensive
reagent benzeneselenol. Townsend's approach requires a low-temperature reduction
step that is incompatible with 5-O-ester protection (e.g., 2d, 2j, 21,2m). Yields of
glycals made herein under Pedersen conditions, including the four previously unknown
glycals 2d, 2j, 21,2m, are comparable to those acheived by Townsend, and the Pedersen
method is always one less step from commercially available material: bis-O-TBDMS
glycal 2e, 2 steps from thymidine (la), 47% yield, or 3 steps from 2-deoxyribose, 63%
yield; bis-OTBDPS glycal 2f, 2-steps from la, 76% yield, or 3 steps from 2deoxyribose, 80% yield; 3-O-TBDPS glycal 2o, 4-steps from la, 53% yield, or 5 steps
from 2-deoxyribose, 20% yield. Gram quantities of furanoid glycals can now be
prepared in a few days using standard nucleoside protection chemistry and typical
HMDS silylation conditions. Improved access to differentially protected 5-member
glycals should greatly increase their potential as intermediates in organic synthesis,
especially for preparation o f aryl- and heteroaryl-2-deoxy-C-furanosides. 17,18
2,5 Experimental
NMR spectra were collected on Broker AC-200, AC-250 or ARX-300 FT NMR
spectrometers.

NMR data are listed in ppm (5) using TMS as an internal reference.
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NMR data are listed in 5 ppm using solvent peaks and TMS as references. The
peaks were assigned with the aid of COSY, DEPT and HETCOR. Melting points were
performed on a Fisher-Johns hot plate apparatus. FABMS was performed on a Finnigan
MAT-900 double sector mass spectrometer equipped with a PATRIC detector or a VG
7070E-HF using m-nitroben^l alcohol (NBA) or glycerol as the matrix. CIMS was
performed on a Finnigan MAT-95 double sector mass spectrometer using NH3 or
isobutane as the carrier gas. Microanalyses were performed by M-H-W Laboratories
(Tucson, Arizona). Colunm chromatogr^hy procedures utilized silica gel (Merck, 230400 mesh) or alu m in a (Aldrich, Basic, Brockman 1 ,150 mesh). Thin layer
chromatography (TLC) was carried out using Merck plates coated with Silica Gel 60
F254 (0.25 mm thickness). Anhydrous DMF was from Aldrich (Sure-Seal bottle), and
pyridine was distilled from CaH;.
2.5.1 Method A. General Conditions for Silylation: Synthesis of S'-0-{tertButyldimethyl)-3-€)-(tlerr-bu^ldiphenylsi]^l)thymidine (1 h).^^
5'-0-(/err-Butyldimethylsilyl)thymidine (lb ) (3J 7 g, 9.46 mmol) was
introduced to a dried flask under Ar. DMF (40 mL) was added, and the solution was
stirred until lb dissolved. Imidazole (2.07 g, 30.40 mmol) was added followed by
TBDPSCl (3.17 g, 11.54 mmol). The solution was stirred for 24 hours. It was poured
into water (500 mL) and extracted with ether (3 x 250 mL). The ether layer was then
washed with aqueous NaHCOs (200 mL) followed by distilled water (200 mL). It was
dried with Na2S04 and ev^x>rated under reduced pressure to give a clear oil. This was
purified by flash chromatogr^hy (hexanes then ether) to yield a white solid (5.5 g,
98%). TLC: ^ 0 .9 1 (9:1 CHCI3-CH3OH); m.p. 56 °C; FABMS (NBA) 596.5 (M +
H)+; IH NMR (250 MHz, CDCI3) 5 9.62 (s, IH, H3), 7.67-7.63 (m, 4H, Ar cmdH 6 ),
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7.47-7.37 (m, 7H, Ar), 6.53 (dd, Jm' = 5.5, Jm- = 8 9 Hz, IH, ff/% 4.34 (d, J = 5.2 Hz,
IH,

4.00 (s, IH,

3.63 (dd, Jh4>= 1-3, V^ = 11.0Hz,lH, ffS% 3.14 (dd, Jh4’ =

1.8, Jh5-= 10.9 Hz, IH,

2.34 (dd, J = 5.3,13.0 Hz, IH, H2% 1.87 (s, 3H, C S -C H i)

1.85-1.82 (m, IH, H2 '), 1.09 (s, 9H, C (C H 3 )3 l 0.78 (s, 9H, C (C H 3 )3 \ -0 07 (s, 3H, S iCH s),

-0.11 (s, 3H, Si-C H s).

NMR (62.9 MHz, CDCI3) S 164.04 (C4), 150.45

(C2), 135.61 (C6), 135.38,133.25,133.03, 129.89,127.77 (Ar), 110.71 (C5), 87.97
(C4% 84.97 (CIO, 74.15 (C30,63.14 (C50,4125 (C20,26.80 ( € ( ^ 3)3), 25.71
(C(CH3)3>, 18.94 (C(CH3)3), 18.11 (C(CH3)3), 12.32 (CH3), -5.60 (Si-CH3), -5.78 (SiCH3).
2,52 Method B. General Conditions for Toinoyiation: Synthesis of 5'-0-{tertBntyldimethylsityl)-3'-t^^toIuoyI)thyniidine (li).
5'-0(rer/-ButyldimethyisiIyl)thyinidine (Ib) (0.207 g, 0.58 mmol) was
introduced to a dried flask under Ar. Pyridine (5 mL) was added and the solution was
cooled to 0 ®C. The /7-toluoyl chloride (0.15 mL, 1.13 mmol) was added slowly over 15
minutes. The solution was allowed to warm to room temperature followed by heating to
50-55 °C for 4 hs. Then, it was cooled to room temperature and poured onto ice
followed by an extraction with CH2CI2. The organic layer was washed with aqueous
NaHCOg and then distilled water. The washed layer was dried with Na2S04 and
concentrated under reduced pressure. It was reciystallized from CH2CI2 to yield a white
soUd (0.219 g, 80%). TLC: R/0.84 (1:2 CH2Cl2-EtOAc); m.p. 173 °C; FABMS (NBA)
475.2 (M + H)+; IH NMR (300 MHz, CDCI3) S 8.84 (s, IH, H3), 7.95-7.92 (m, 2H,
Ar), 7.61 (app d, /mc = 1.2 Hz, IH, ffâ), 7.28-7.25 (m, 2H, Ar), 6.48 (dd, J ic = 5.3, Jia= 9.3 Hz, IH, fflO , 5.49 (d, / = 6.1 Hz, IH, H3% 4.25 (s, IH,

4.04 (dd,
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JH y=ll-3H z, lH,Æ?'),3.97(dd,yH4 = 1.9,yH5’= n .3 H z , \H,H5% 2.5% idd,Jw =
5.3, JHZ' = 13.8 Hz, IH, H2% 2.42 (s, 3H, CS-CHj), 2.27-2.19 (m, IH, H2'), 1.95 (c^^hô
= 1.0 Hz, 3H, Ar-CHj), 0.96 (s, 9H, CrCBj^s), 0.17 (s, 6H, S 1-CH3). l^C NMR (75
MHz,CDCl3) 6 166.28 (C(O)-Ar), 163.64 (C4), 150.40 (C2), 144.38 (C(O)-Ar), 135.12
(C6), 129.77,129.26 (Ar), 126.57 (Ar-CHj), 11127 (C5), 85.66 (C4'), 84.86 (Cl"),
75.84 (C3"), 63.74 (C5’>, 38.21 (C2’), 25.91 (€ (€ « 3)3), 21.72 (Ar-CHj), 18.37
(C(CH3>3), 12.52 (C5 -CH3), -5.34, -5.43 (Si-CHj). Calcd for C24H34N206Si*H20: C
58.51, H 7.37, N 5.69. Found: C 58.38, H 6.72, N 5.78.
2JS3 Method C. General Conditioiis for Detoluoylation: Synthesis of 3'-0-(/er/Butyldhnethyb%l)thymidine (ln).29
3'-0-(/e/t-Butyldimethylsilyl)-5-0-(p-toluoyl)thymidine (II) (0.062 g, 0.13
mmol) was introduced into a dried flask under N2. NH3-saturated CH3OH (10 mL) was
added. Additional NH3(g) was bubbled through the solution for 5 min, and the reaction
was left to stir for 24 hs. It was evaporated under reduced pressure to an oil that was
purified by flash chromatography (EtOAc) to yield a Wiite solid (0.044 g, 95%). TLC:
Rf 0.12 (EtOAc); m.p. 90 ®C (lit 83-84 °C); FABMS (glycerol) 357.2 (M + K f ; iH
NMR (200 MHz, CDCI3) S 8.88 (hr, IH, MS'), 7.37 (app d, 2 mc =11 Hz, IH, H6 % 6.14
iUJ= 6.7, IH, Hl% 4.49 (m, IH, //i% 3.96-3.89 (m, 2H, H 4’and MS'), 3.76 (m, IH,
H5X 2.72 (br, OH), 2.43-2.15 (m, 2H, H2% 1.91 (d, Jke = 0.9 Hz, 3H, CS-CHj), 0.89
(s, 9H, C(CH3) 3), 0.09 (s, 6H, &-C%). 13C NMR (62.9 MHz, CDCI3) 8 163.67 (C4),
150.30 (C2), 136.98 (C6), 110.99 (C5), 87.58 (C4*), 86.94 (C l'), 71.60 (03*), 62.02
(C5'), 40.48 (C2") 25.69 ( € ( ^ 3)3), 17.93 (C(CH3)3), 12.47 (C 5 -CH3), -4.72, -4.87 (81CH3).
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2.5.4 Method D. General Conditions for Gfycal Formation: Synthesis of 1,4Anhydro-3 ,5-bis-O-(/eft-bntyldiphenyisilyi)-2 -deo^-D-eiylftr0 -pent-l-enitol(2 f).2 ^
3', 5'-Bis-0-(rerf-butyldiphenylsilyl)thymidine (If) (0.99 g, 1.38 mmol) was
introduced to a dried flask under Ar. HMDS (10.0 mL, 47.3 mmol) was added and the
solution was stirred until dissolved. After the addition of the (NH^^gSO^ (0.29 g, 2.19
mmol), the solution was refluxed for 4 hours. The HMDS was evaporated under
reduced pressure and the residue was partitioned between water and cyclohexane. The
organic layer was washed with aqueous NaHCOs and then distilled water. It was dried
with Na2S04 and evaporated under reduced pressure to give a yellow oil that was
purified by alumina flash chromatography (1:2 ether-hexanes) (0.648 g, 79%). TLC: R f
0.65 (1:2 ether-hexanes); FABMS (NBA) 591.3 (M - H)^; ‘H NMR (200 MHz, CDCI3)
6 7.79-7.62 (m, 9H, Ar), 7.48-7.36 (m, IIH , Ar), 6.51 (d, Jh2 = 2.3 Hz, IH, HI), 4.99 (t,
y= 2.0 Hz, IH, H2), 4.92 (m, IH, H3), 4.59-4.53 (m, IH, H4), 3.49-3.45 (m, 2H, HS),
1.12,1.03 (2s, 18H, C(CHs)3).

NM R(50 MHz, CDCI3) S 149.28 (Cl), 135.80,

135.61,134.96, 134.86, 134.15, 134.01, 129.66, 129.34,127.68, 127.51 (Ar), 103.43
(C2), 89.17 (C3), 76.99 (C4), 63.80 (C5), 26.93,26.77 (C(CH3)3>, 1922, 19.07
(C(CH3)3).

2.5.5 Synthesis of 5'-0-(^^'*Butyldimethylsifyl)thymidine (Ib).^^
Prepared according to Method A from la (0.402 g, 1.66 mmol) and TBDMSCI
(0.320 g, 2.12 mmol). Product was purified by flash chromatography (EtOAc) to yield a
white sohd (0.505 g, 71%). TLC: RfO.57 (9:1 CH2CI2-CH3OH); m.p. 200 °C (lit 198199 ®C); FABMS (NBA) 357.3 (M + H)+; *H NMR (300 MHz, CDCI3) Ô 8.56 (br, IH,
H3), 7.52(appd,JMe= 11 Hz, IH ,H 6 ), 6.38 (dd, Jh2 = 8-U^H2-= 5.7Hz, IH,H1%
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4.46 (br, IH, MS'), 4.05 (dd, J = 4.7,2.6 Hz, IH, H4% 3.90 (dd, Jhs- = 11 -3, Jwv = 2.7
Hz, IH, H5% 3.83 (dd,

=11.3, Jwv = 2.6 Hz, IH, MS'), 2.65 (br, IH, OH), 2.38 (ddd,

Jvx ~ 13.5, J\\\' —5.7, t/H3' ~ 2.3 Hz, IH, H2% 2.10 (ddd, Jh2' ~ 13.5, ^Hr ~ 8.0, J\q< —5.8
Hz, IH, H 2 \ 1.92 (d, Jh6=1.0 Hz, 3H, C5-C%), 0.92 (s, 9H, C(CH^i), 0.12,0.11 (2s,
6H, Si-CHs). 13C NMR (75 MHz, CDCI3) 5 164.0 (C4), 150.6 (C2), 135.7 (C6), 111.1
(C5), 87.4 (C4'), 85.2 (Cl*), 72.8 (C3*), 63.8 (C5*>, 41.3 (C2*), 26.1 (€ (€ ^ 3)3), 18.6
(C(CH3>3), 12.7 (C5-CH3), -5.2, -5.3 (Si-CHj).
2.5.6 Synthesis of 5*-0-(/err-Butyldlphenylsilyi)thyniidlne (lc).2530
Prepared according to Method A from la (0.211 g, 0.87 mmol) and TBDPSCl
(0.159 g, 0.58 mmol). It was purified by flash chromatography (EtOAc) to yield a white
soUd (0.322 g, 77%). TLC: R/0.37 (1:2 CHiCli-EtOAc); m.p. 162 °C (lit 163-164 °C);
FABMS (glycerol) 481.3 (M + H)+; ^H NMR(300 MHz, CDCI3) Ô 8.57 (br, IH, H 3\
7.67-7.64 (m, 4H, A r\ 7.48-7.37 (m, 7H, H6 andAr), 6.39 (dd, Jm.' = 5.7, Jm' = 8.1 Hz,
IH, HI'), 4.57 (br, IH, iW*), 4.02-3.95 (m, 2H, H4'andH5'), 3.85 (dd,
= 2.1 Hz, IH, H 5 \ 2.40 (ddd,

= 10.8, J ^ '

= 13.5, Jh3-= 7.8, /„!• = 2.6 Hz, IH, H2'), 2.25-2.15

(m, 2H, H 2'and OH), 1.64 (s, 3H, CHj), 1.09 (s, 9H, C(CHs)3). *^C NMR (62.9 MHz,
CDCl3)S 135.7 (Ar), 135.5 (C6), 133.1,132.6,130.4, 130.3, 128.2 (Ar), 111.2 (C5),
87.1 (C4*), 84.7 (Cl*), 72.2 (C3*) 64.1 (C5*), 41.0 (C2*) 27.0 (C(CH3)3), 19.4 ( € ( ^ 3)3),
12.1 (C5-CH3).
2.5.7 Synthesis of 5’-0-(p-toluoyl)thymidme(ld).31
Prepared according to Method B from la (1.977 g, 8.16 mmol). The product
was recrystallized from CH2CI2 to yield a white solid (2.170 g, 74%). TLC: R f 0.62
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(9:1 CH2CI2-CH3OH); m.p. 198 ®C (lit. 202 ®C); FABMS (glycerol) 361.0 (M + H)+;
NMR (250 MHz, CDCI3) 5 8.22 (br, IH, H 3\ 7.92 (d, Jf^ = 8.0 Hz, 2H, Ar), 7.56 (s,
7.28-7.26 (m, 2H, Ar), 6.35 (dd,

IH,

= 6.9,

= 12.9 Hz, IH,

Jh4*= 2.9 Hz, 2H, 7^5"), 4.52 (br, IH, i/i*), 4.26 (d, 7 = 2.3 Hz, IH,

4.61 (d,
2.57-2.52 (m,

IH, /KO, 2.43 (s, 3H, CHs-Ar), 2.24-2.13 (m, IH, H2% 1.61 (s, 3H, CS-CHj), 1.43 (br,
O//).

NMR (62.9 MHz, CDCI3) Ô 167.2 (C(0)>, 163.1 (C4), 144.6 (Ar-C(O)),

134.9 (C6), 129.62,129.4 (Ar), 129.3 (Ar-CHj), 111.1 (C5), 85.0 (C40,84.6 (Cl*), 71.6
(C30,63.7 (C50,40.7 (C2'), 21.7 (CHj-Ar), 12.3 (C5-CH3).
2,5.8 Synthesis of 3*,5*-Bis-0-(tleif-batyldimethybifyl)thymidme (le).29
Prepared according to Method A from la (1.073 g, 4.43 mmol), twice the
amount of imidazole (0.722 g; 10.60 mmol), and TBDMSCI (1.70 g; 11.28 mmol). It
was purified by flash chromatography using 6:1 hexanes-ether to yield a white solid
(1.41 g, 68%). TLC: R f0.6\ (1:2 CHiCli-EtOAc); m.p. 140 °C (Ut. 144-145 °C);
FABMS (glycerol) 471.4 (M + H)+; ‘H NMR (300 MHz, CDCI3) 6 9.33 (s, IH, H3),
7.47 (app d, Ace = 1.2 Hz, IH, H6 ), 6.34 (dd, Ac’ = 7.8, Ac- = 5.8 Hz, IH, Hl% 4.41 (m,
IH, 70% 3.94 (d, J = 2.4 Hz, IH, H4), 3.89 (dd, Acs- =11.3, Ac4-=2.6 Hz, IH, 70% 3.76
(dd, Acs' —11.4, Ac4‘= 2.5 Hz, IH, 775% 2.26 (ddd, Acr = 5.8, A c = 2.7, A c = 13.1 Hz,
IH, 772% 2.02 (m, IH, 772% 1.92 (d, Ae = 11 Hz, 3H, C5-C%), 0.93,0.90 (2s, 18H,
C(CH3)3), 0.12,0.08 (2s, 6H, Si-CHs).

NMR (75 MHz, CDCI3) S 164.2 (C4),

150.6 (C2), 135.6 (C6), 111.0 (C5), 88.0 (C4% 85.0 (Cl% 72.4 (C3% 63.1 (C5% 41.6
(C2% 26.1,25.9 (C(CH3)3), 18.6, 18.2 (C(CH))3), 12.7 (C5-CH3), -4.5, -4.7, -5.2, -5.3
(SÎ-CH3).
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2.5.9 Synthesis of 3 %S-Bis-O^^f^butylphenybilyiythynudine (If).^^
Prepared according to Method A from la (0216 g, 0.90 mmol), twice the
amount of imidazole (0.333 g; 4.88 mmol), and TBDPSCl (0.317 g; 1.15 mmol). It was
purified by flash chromatography with 1:2 EtOAc-hexanes to yield a clear oil (0.63 g,
95 %) TLC: R/O M (1:2 CHzClz-EtOAc); FABMS (NBA) 719.5 (M + H)+;

NMR

(300 MHz, CDCI3) Ô9.51 (s, IH, H3), 7.65-7.25 (m, 21H, Ar and H6), 6.55 (dd, Jh2’=
8.8, Jh2' = 5.3 Hz, ih , ///% 4.56 (d, J = 5.1 Hz, IH, H3% 4.01 (s, IH, H4'), 3.76 (d, Jus'
= 11.5 Hz, IH, H5X 3.32 (d, Jhs- = H-4 Hz, IH, MS'), 2.36 (m, IH, HZ’), 1.97 (m, IH,
HZ’), 1.52 (s, 3H, C5 -CH3), 1.09,0.94 (2s, 18H, C(C%)j).

NMR (62.9 MHz,

CDCl3)6 164.3 (C4), 150.7 (C2), 135.9, 135.8,135.6, 135.5, 133.4, 133.3,133.1,
132.3, 130.2,130.1,127.9 (Ar), 111.3 (C5), 87.9 (C4"), 84.9 (Cl"), 74.1 (C3"), 64.2
(C5"), 41.5 {CT), 27.1 (dC H sh). 19.4, 19.2 (C(CH3)3), 12.1 (C5-CH3).
2.5.10 Synthesis of 3\5-Bis-0-(p-toluoyi)thymidine (Ig).^^
Prepared according to Method B from la (2.064 g, 8.52 mmol) and an excess of
/7-toluoylchloride (5.845 g; 37.81 mmol). It was purified by recrystalization from
CH2CI2 to yield a white solid (2.87 g, 70%). TLC: RfOA9 (1:2 ether-hexanes); m.p.
167 °C (lit. 143 «C); FABMS (NBA) 479.3 (M + H)+; *H NMR (300 MHz, CDCI3) 5
7.97-7.90 (m, 4H, Ar), 7.80 (d, J = 8.3 Hz, 2H, Ar), 7.36 (app d, J = 1.2 Hz, IH, H6),
7.31-7.23 (m, 2H, Ar), 6.45 (dd, Jm' = 5.4,

= 8.8 Hz, IH, ///'), 5.6 (d, J= 6.5 Hz,

IH, HZ’), 4.82 (dd, Jy^ = 2.9, Jhs- = 12.3 Hz, IH, HZ’), 4.67 (dd, J ^ ' = 3.3, Jhs* = 12.3
Hz, IH, HZ’), 4.53 (dd, 7h5- = 2.9, Jm- = 5.1 Hz, IH, H4’), 2.72 (ddd, J hv = 5.4,

=

1.3, Jyu' = 14.2 Hz, IH, HZ'), 2.44 (s, 3H, Ar-CHj), 2.41 (s, 3H, Ar-CHj), 2.39-2.29 (m.
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IH, H2X 1.66 (d, Jm = 0.9 Hz, 3H, CS-CHi).

NMR (75 MHz, CDCI3) 6 168.4,

166.1 (C(0)-Ar), 162.5 (C4), 149.3 (C2), 146.4, 144.7 (C(O)-Ar), 134.1 (C6), 130.6,
129.9,129.6,129.3, 129.0 (Ar), 126.6,126.2 (Ar-CHj), 111.7 (C5), 85.2 (€4*), 83.0
(Cl-), 74.9 (C3"), 64.1 (C5’>, 38.1 (C2*), 21.9,21.7 (Ar-CHj), 12.3 (C5-CH3).
2.5.11 Synthesis of 3'-0-(/err-batyidimethylsifyl)-5*-0>(/e/t-batyldiphenylsilyl)
thymidine (lj).30
Prepared according to Method A from Ic (0.762 g, 1.59 mmol) and TBDMSCI
(0.60 g, 3.98 mmol). The product was purified by flash chromatography (1:3 etherheanes) to yield a white solid (0.844 g, 89%). TLC:

0.87 (EtOAc); m.p. 69 °C;

FABMS (NBA) 596.0 (M + H)+; ^H NMR (250 MHz, CDCI3) 8 8.05 (s, IH, H 2\ 7.677.64 (m, 4H, Ar), 7.48-7.31 (m, 7H, Ar cmdH6 ), 6.36 (dd, Jh2’ ~ 8.0, Jh2’ “ 5.8 Hz, IH,
H n , 4.50 (d y = 5.8 Hz, IH, MS'), 3.96 (m, 2H, H4’andH5% 3.77 (dd, 7h4- = 3.6, Jhs’ =
12.5 Hz, IH, H5% 2.28 (ddd, J»r = 10.8, J w = 5.7, Jm- = 3.2 Hz, IH, H2% 2.10 (m,
IH, H2'), 1.64 (s, 3H, C5-OT,), 1.09 (s, 9H, C(CH^3\ 0.87 (s, 9H, C(CH^i), 0.018 (s,
3H, Si-CMs), 0.00 (s, 3H, Si-CHs).

NMR (50 MHz, CDCI3) 8 163.9 (C4), 150.3

(C2), 135.0,134.8, 132.3, 131.9, 129.6,127.5 (Arand C6), 110.6 (C5), 87.2 (C4"), 84.2
(Cl"), 71.7 (C3"), 63.2 (C5"), 41.0 (C2"), 26.5,25.3 (C(CH3)3), 18.8,17.5 (C(CH3)3),
II.7 (C5-CH3), -5.1, -5.4 (Si-CH3).
2.5.12 Synthesis of 5 -0-(tkrt-Bn^ldiphenybilyl)-3-0-(^tolnoyl)thym idine (Ik).
Prepared according to Method B from Ic (1.026 g, 2.19 mmol). The product
was purified by recrystallization using CH2CI2 to yield a white solid (0.888 g; 69%).
TLC: /Î/0.84 (1:2 CH2CI2 -EtOAc); m.p. 170 ®C; FABMS (NBA) 599.4 (M + H)+; ^H
NMR (250 MHz, CDCI3) 8 9.46 (s, IH, Æ3), 7.96-7.93 (m, 2H, Ar), 7.72-7.67 (m, 4H,
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ArX 7.55 (br, IH, Ar), 7.46-7.37 (m, 6H, Ar and H6), 1728-7.25 (m, 2H, Ar), 6.55 (dd,
Jm' = 5.2,

= 9.2 Hz, IH, H2% 5.71 (d, J= 6.0 Hz, IH, H3% 4.24 (br, IH, H 4 \ 4.08

(br, 2H, US'), 2.63 (dd, Jh2- = 5.4, Jh2- = 13.8 Hz, IH, H2’), 2.45-2.17 (m, 4H, H2’ and
CHs-Ar), 1.56 (s, 3H, CS-CHj), 1.13 (s, 9H,

NMR (62.9 MHz, CDCI3) Ô

166.1 (C(0)-Ar), 163.8 (C4), 150.6 (C2), 144.23 (C(O)-Ar), 135.5, 135.2, 134.9,133.0,
132.1,130.1,130.0, 129.7, 129.2, 128.1, 128.0 (Ar), 126.6 (Ar-CHj), 111.6 (C5), 85.2
(C4*), 84.4 (Cl*), 75.2 (C3’), 64.3 (C5’), 38.1 (C2"), 27.0 (C(CH3)3), 21.7 (Ar-CHj), 19.4
(C(CH3>3), 11.9 (C5-CH3). Anal. Calcd for C34H3gN206Si: C 68.20. H 6.40, N 4.68.
Found: C 67.96, H 6.17, N 4.64.
2,5.13 Synthesis of 3 -0 -(t^rt^Bn^ldimethylsilyI)-S-<X^toluoyI)-thym:dine (II),
Prepared according to Method B from Id (0.48 g, 1.33 mmol). Purification was
done by recrystallization fix>m CH2CI2 to yield a white solid (0.4508 g, 71%). TLC: R f
0.52 (9:1 CHCI3-CH3OH); FABMS (glycerol) 475.1 (M + H)+; ‘H NMR (250 MHz,
CDCI3) 5 7.90 (d,
6.6 Hz, IH,

= 7.8 Hz, 2H, Ar), 7.28-7.25 (m, 3H, Ar and H6), 6.30 (t, J^^. =

"), 4.61 (dd,

= 3.6, ^ 5. = 12.5 Hz, IH, MS'), 4.49-4.43 (m, 2H, H3’

and MS’), 4.20 (dd, J= 3.6,6.9 Hz, IH, H4'), 2.43 (s, 3H, Ar-CHj), 2.37 (ddd, J ^ . =
2.7,

= 6.0,

= 13.7 Hz, IH, H2'), 2.16-2.05 (m, IH, H2'), 1.67 (s, 3H, C S-C H j),

0.90 (s, 9H, C (C H s)), 0.10 (s, 6H, S i-C H i). ‘^C NMR (62.9 MHz, CDCI3) 6 166.2
(C(0)), 163.4 (C4), 150.0 (C2), 144.4 (Ar-C(O)), 135.0 (C6), 129.5 (Ar), 129.4 (Ar),
126.7 (Ar), 111.1 (C5), 85.5 (C40, 85.1 (Cl*), 72.0 (C3"), 63.6 (C5"), 41.2 {C l), 25.7
(C(CH3)3), 21.7 (Ar-CH3), 17.9 (C(CH3)3), 12.2 (C5-CH3), -4.7, -4.8 (Si-CH3). Anal.
Calcd for C24H34N206S1: C 60.73, H 7.22, N 5.90. Found: C 61.20, H 7.05, N 5.75.
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2^.14 Synthesis of 3*-0-{t<ert‘-Batyidiphenyisifyl)-5'-0-(/^-tolaoyI)thymidme(lm).
Prepared according to Method B from Id (0.600 g, 1.66 mmol). The product
was purified by recrystallization fix)m CH2CI2 to yield a white solid (0.9211 g, 92%).
TLC: ^0 .4 8 (9:1 CHCI3-CH3OH); m.p. 74 °C; FABMS (glycerol) 599.0 (M + H)+;
•H NMR (250 MHz, CDCI3) 5 8.03 (br, H3), 7.74 (d,
4H, Ar), 7.45-7.33 (m, 6H, Ar and H6), 7.23 (d,
IH, Hl% 4.48-4.44 (m, IH, H3% 4.34 (dd,
(dd, J= 2.9,5.9 Hz, IH, H4% 3.86 (dd,

2H, A r \ 7.69-7.63 (m,

= 7.2,2H, Ar), 6.40 (t,J= 7.2 Hz,
= 2.9,

= 3.3,

= 12.6 Hz, IH, H 5 \ 4.22
= 12.0 Hz, IH, H5% 2.51-2.42

(m, IH, H2'), 2.42 (s, 3H, Ar-CHs), 1.99-1.88 (m, IH, H2% 1.53 (s, 3H, C5 -CH3), 1.10
(s, 9H, C(C%)j). »3c NMR (50 MHz, CDCI3) Ô 165.9 (C(0)), 163.2 (C4), 149.9 (C2),
144.4 (Ar-C(O)), 135.7, 134.8, 132.8,130.3,130.2, 129.5, 129.3, 128.0,127.7 (Ar),
126.6 (Ar-CHs), IH l (C5), 85.0 (C4% 73.0 (C3’), 63.4 (C5"), 41.0(C2"), 26.9
(C(CH3)s), 21.7 (Ar-CHj), 19.0 (C(CHs)3), 12.1 (C5-CH3). Anal. Calcd for
C34H3gN206Si: C 68.20, H 6.40 N, 4.68. Found: C 67.99, H 6.45, N 4.46.
2.5.15 Synthesis of 3*-0-(l!ert-BntyldiphenylsilyI)thymidine (lo).^^
Prepared according to Method C finm Im (0.349 g, 0.58 mmol). The product
was purified by flash chromatography using 1:2 CH2Cl2-EtOAc to yield a white solid
(0.279 g, 99%). TLC: R/0.33 (1:2 CH2Cl2-EtOAc); m.p. 89 °C (lit. 77 °C); FABMS
(glycerol) 481.6 (M + H)+; ‘H NMR (200 MHz, CDCI3) 5 9.29 (br, IH, H3), 7.17-7.62
(m, 4H, Ar), 7.46-7.32 (m ,7U ,A rand H6), 6.26 (dd, J^^ = 6.2, J^^. = 7.7 Hz, 1H, HI %
4.45 (m, IH, m X 3.98 (d, J= 2.6 Hz, IH, H4'), 3.63 (d, J = 12.0 Hz, IH, MS'), 3.25 (d,
y = 11.7 Hz, IH, MS'), 2.64 (br, IH, OH), 2.26 (ddd,

= 5.9,

= 11.5, Jy^y = 2.8 Hz,

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

33

IH, H2'), 2.16 (m, IH, H2% 1.82 (d, 7 = 0.7 Hz, 3H, C5-CHjX 1.08 (s, 9H,
13c NMR (50 MHz, CDCI3) 6 163.4 (C4), 1502 (C2), 136.8, 135.7,133.1, 130.1,
127.9,127.9 (A t an d C6), 1 11.0 (C5), 87.7 (C4*), 86.9 (Cl"), 73.0 (C3’), 62.1 (C5% 40.3
(C2-), 26.9 (C(CH3)3), 19.0 (CCCHg)]), 12.5 (C5-CH3).
2.5.16 Synthesis o f l,4-Anhydro-2-deoxy-D-eiyt/tro-pent-l-enitol (2a).^^

Prepared according to Method D from la (96 mg, 0.40 mmol) and (NH4)2S04
(0.157 g, 1.19 mmol) in 5 mL o f HMDS. No extraction was performed and the product
was isolated by alum ina flash chromatogr^hy (1:2 ether-hexanes) to yield a yellow oil
(0.0367 g, 80%). TLC: R f 0 2 4 (1:2 ether-hexanes); CIMS (isobutane) 117.1 (M + H)+;
IH NMR (250 MHz, CDCI3) Ô6.49 (d, Jm = 2.3 Hz, IH, HI), 5.02 (t,J = 2.4 Hz, IH,
H2), 4.81 (m, 1H, H3), 4.31 (dt, J = 2.5,6.5 Hz, 1H, H4), 3.65 (dd, J = 5.9, 10.7 Hz,
IH, H5), 3.43 (dd, J= 6.8, 10.7 Hz, IH, H5).

NMR (50 MHz, CD3OD) Ô 150.55

(Cl), 104.27 (C2), 90.57 (C3), 76.08 (C4), 63.27 (C5).
2.5.17 Synthesis o f l,4-Anhydro-5-0-(/err-batyldimethylsilyl)-2-deoxy-D-efylAropent-l-enitol (2b).22

Prepared according to Method D from lb (0.502 g, 1.41 mmol), HMDS (7 mL,
33.2 mmol), and (NH4)2S04 (0.196 g, 1.48 mmol). The product was purified by
alumina flash chromatography (1:2 ether-hexanes) to yield a yellow oil (0.24 g , 74%).
TLC: ^/0.98 (9:1 CHzClj-EtOAc); CIMS (NH3) 230.2 (M + H)+, 247.2 (M + NH»)^;
•H NMR(250 MHz, CDCI3) Ô6.53 (d,
H2), 4.78 (br, IH, H3), 4.33 (dt,

= 2.36 Hz, IH, HI), 5.14 (t, J = 2.9 Hz, IH,

= 5.8, ^ 3 =2.9 Hz, IH, H4), 3.71 (dd,

= 10.7,

= 5.8 Hz, IH, H5), 3.51 (m, IH, H5), 1.60 (br, IH, OH), 0.89 (s, 9H, C(CH3) 3 ),
0.07,0.06 (2s, 6H, S1-CH 3 ). ‘^C NMR (62.9 MHz, CDCI3) 6 150.11 (Cl), 103.11 (C2),
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89.31 (C3), 75.67 (C4), 62.90 (C5), 25.83 (C(CH3)3), 18.29 (C(CH3)3), -5.36 (SiCH3).
2^.18 Synthesis of l,4-Anhydro-S-0-(tleft^butyid:phenylsUyi)-2-deo:qr-D-gfythropent-l-enitol (2c).24
Prepared according to Method D from Ic (0.302 g, 0.63 mmol), HMDS (1 mL,
4.74 mmol), and (NH4)2S0 4 (0.350 g, 2.65 mmol). The product was purified by
alumina flash chromatography (1:2 ether-hexanes) to yield a yellow oil (0.204 g, 91%).
TLC: RfQJ9 (1:2 ether-hexanes); IH NMR (250 MHz, CDCI3) 5 7.77-7.74 (m, 4H,
Ar), 7.51-7.40 (m, 7H, Ar), 6.56 (d, J ^ = 2.6 Hz, IH, HI), 5.10 (t, J = 2.8 Hz, IH, H2),
5.04 (m, IH, H3), 4.45 (dt,
^ 5=10.8 Hz, IH, H5), 3.70 (dd,

= 2.4, ^^5 = 5.2 Hz, IH, H4), 3.80 (dd, Jy^^ = 5.0,
= 5.8,

= 10.7 Hz, IH, H5), 1.11 (s, 9H,

C(CH3) 3 ). 13C NMR (62.9 MHz, CDCI3) 6 149.38 (Cl), 135.62, 134.0, 133.34,
129.73,127.71 (Ar), 103.29 (C2), 88.80 (C3), 75.73 (C4), 63.66 (C5), 26.81
(C(CH3)3), 19.29 (C(CH3)3).
2,5.19 Synthesis of l,4-Anhydro-5-0^p-toluoyl)-2-deoxy-D-erytAm-pent-l-enitol
(2 d).
Prepared according to Method D from Id (0.0369 g, 0.102 mmol), HMDS (1
mL, 4.74 mmol), and (NH4)2S04 (0.3 g, 2.3 mmol). The product was purified by
alumina flash chromatography (1:2 ether-hexanes) to yield a clear oil (0.012 g, 52%).
TLC: R f 0.67 (1:2 ether-hexanes); HR-FABMS (MNBA) theoretical (M + H)^
235.0970. Found: 234.0948; ‘H NMR (250 MHz, CDCI3) 6 7.96, (d,
Ar), 7.20 (d,

= 8.2 Hz, 2H, Ar), 6.49 (d,

= 8.47 Hz, 2H,

= 2.0 Hz, IH, HI), 4.95 (t, J = 2.74 Hz,

IH, H2), 4.87 (m, IH, H3), 4.70 (m, IH, H4), 3.99 (m, 2H, HS), 2.41 (s, 3H, Ar-CH3 ).
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13C NMR (50 MHz CDCI3) 5 165.87 (C(0)-Ar), 149.06 (Cl), 143.34 (C(O)-Ar),
129.38,128.74 (Ar), 127.35 (Ar-CHs), 103.09 (C2), 86.01 (C3), 76.77 (C4), 63.68
(C5), 2128 (tol-CHs). Anal. Calcd for C,3H,404: C 66.66, H 6.02. Found: C 66.58, H
6.05.
2.520 Synthesis of l,4-Anhydro-3,5-bis-0-(teit-butyldiniethyIsUyl)-2-deoxy-Derytbro-pent-l-emitol (2e).24
Prepared according to Method D from le (1.055 g, 2.24 mmol) and (NH4)2S04
(0.61 g, 4.62 mmol) in 10 mL HMDS. Yielded a yellow oil (0.534 g, 69%) after
purification by alumina flash chromatography (1:2 ether-hexanes). TLC: RfO.%6 (1:2
CHiClz-EtOAc); «H NMR (300 MHz, CDCI3) 5 6.45 (d,
2.50 Hz, IH, H2), 4.87 (br, IH, H3), 4.28 (dt,

= 2.6 Hz, IH, HI), 5.00 (t,

= 2.7,^ 5 = 5.9 Hz, IH, H4), 3.69

(dd,J„4 = 5.6,y „5 = 10.6 Hz, lH ,//5),3.50(dd,y„^ = 6.4,yH5= 10.6Hz, IH ,m ), 0.90,
0.89 (2s, 18H, C(CH3) 3 ), 0.08, 0.06 (2s, 12H, Si-CH3 ). l^C NMR (75 MHz, CDCI3) 6
149.16 (Cl), 103.56 (C2), 89.14 (C3), 76.21 (C4), 63.00 (C5), 26.08,25.91 (C(CH3)s),
18.57,18.27 (C(CHs)3), -4.06 (Si-CHs), -4.21 (Si-CHg), -5.12 (Si-CHg).
2.521 Synthesis of l,4-Anhydro-5-0-(/erf-bntyldimethylsUyI)-3-0-(^^'^~
butyidipbenylsifyl)-2-deoxy-D-eiyl‘/rro-pent-l-enito! (2b),^^
Prepared according to Method D from lb (1.80 g, 3.03 mmol) and (NH4)2S04
(0.55 g, 4.16 mmol). The product was purified by alumina flash chromatography (1:1
ether-hexanes) to yield a yellow oil (1.12 g, 79%). TLC: Rf 0.12 (1:2 ether-hexanes);
CIMS (NH3) 469.3 (M + H)+, 486.3 (M + NH4)+; ‘H NMR (200 MHz, CDCI3) Ô 7.577.49 (m, 4H, Ar), 7.23-7.19 (m, 6H, Ar), 6.30 (br, IH, HI), 4.86 (m, 2H, H2 andH3),
4.23 (br, IH, H4), 3.61 (dd,

= 5.2,

= 10.9 Hz, IH, H5), 3.51 (dd,
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10.9 Hz, IH, H5), 0.94,0.76 (2s, 18H, C(CH3) 3 %-0.07 (s, 6H, Si-CH3 ). l^C NMR (50
MHz, CDCI3) S 149.19 (Cl), 135.62,134.95,133.32,129.78,127.76,127.54 (Ar),
103.48 (C2), 89.04 (C3), 76.13 (C4), 63.73 (C5), 26.87,25.95 (C(CH3 )3 ), 19.30, 18.06
(C(CH3)3), -4.09 (Si-CHs), -4.29 (Si-CHs).
2.5.22 Synthesis of l,4-Anhydro-3-f>-(/ert-biityldlmethylsiiyl)-S-f^/errbutyldiphenybifyI)-2-deo]i^-D-efythiv-pent-l -enitol (2j).
Prepared according to Method D from I j (0.72 g, 1.21 mmol) and (NH4)2S04
(0.60 g, 4.54 mmol). The product was purified by alumina flash chromatography to
yield a yellow oil (0.337 g, 59%). TLC: RfQ.19 (1:2 EtOAc-hexanes); HR-FABMS
(MNBA) theoretical (M - H)+ 467.2438. Found: 467.2430; >H NMR (250 MHz,
CDCI3) Ô7.72-7.66 (m, 4H, A r\ 7.46-7.37 (m, 6H, Ar), 6.52 (d,
5.06 (m, IH, H2), 4.99 (m, IH, H 3\ 4.38 (dt,
= 5.5,

= 10.9 Hz, IH, //5), 3.67 (dd,

= 5.1 Hz, IH, H4), 3.74 (dd,

= 3.1,
= 5.2,

0.91 (2s, 18H, C(CH3) 3 ), 0.01 (s, 6H, Si-CH3 ).

= 2.6 Hz, IH, H l\

= 10.8 Hz, IH, H5), 1.09,

NMR (50 MHz, CDCI3) S 149.12

(Cl), 135.60,129.66, 127.65 (Ar), 103.47 (C2), 89.01 (C3), 76.01 (C4), 63.67 (C5),
25.84,25.66 (C(CHs)s), 19.22 (C(CHs)3), -4.22, -4.41 (Si-CHs). Anal. Calcd for
C27H4o03Si2: C 69.18, H 8.60. Found: C 68.91, H 8.77.
2.5.23 Synthesis of l,4-Anhydro-3-0-(/ert-batyldimethylsilyl)-5-0-(p-toluoyi)-2deoxy-D-eiy/Aro-pent-l-enitol (21).
Prepared according to Method D from II (0.114 g, 0.24 mmol) and (NH4)2S04
(0.210 g, 1.59 mmol). A yellow oil (0.062 g, 74%) was obtained after purification by
alumina flash chromatogr^hy. TLC: RfQXl (1:2 EtOAc-hexanes); HR-FABMS
(MNBA) theoretical (M + H)"^ 349.1835. Found: 349.1830; ‘H NMR (250 MHz,
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CDCls) 6 7.97, (d, ,(^=8.1 Hz, 2H, Ar), 7.28 (d,

= 9.6 Hz, 2H, Ar), 6.58 (d,

= 2.6

Hz, IH, i/7), 5.25 (t, y = 2.5 Hz, IH, ff2), 5.05 (m, IH, ffJ), 4.74 (dt, J= 2.9,5.9 Hz,
IH, H4), 4.48 (d,

= 5.9 Hz, 2H, H5), 2.44 (s, 3H, Ar-CHj), 0.92 (s, 9H, C(CH3)3\

0.08 (s, 6H, Si-CH3 ).

NMR (50 MHz CDCI3) Ô 166.38 (C(O)-Ar), 149.06 (Cl),

143.82 (C(O)-Ar), 129.74,129.06 (Ar), 126.98 (Ar-CHs), 103.57 (C2), 86.33 (C3),
76.35 (C4), 64.10 (C5), 25.77 (C(CH3)3), 21.62 (tol-CHs), 18.01 (C(CH3)3), -4.30, 4.48 (Si-CHs). Anal. Calcd for Ci9H2g04Si: C 65.48, H 8.10. Found: C 65.63, H 8.23.
2.524 Synthesis of l,4-Anhydro-2-deoxy-3'-0-(/eit-butyIdiphenylsifyl)-5*-0-</7toIuoyl)-D-eiyl!frro-pent-l-enitol (2m).
Prepared according to Method D from Im (1.26 g, 2.10 mmol) and (NH|)2S04
(0.708 g, 5.36 mmol). A yellow oil (0.93 g, 94%) was obtained after purification by
alumina flash chromatography (EtOAc). TLC: 7^0.88 (1:2 EtOAc-hexanes); HRFABMS (MNBA) theoretical (M + H)+ 473.2148. Found: 473.2148; iH NMR (200
MHz, CDCI3) 6 7.83 (d,
Ar), ( 7.20 (d,

= 7.9 Hz, 2H, Ar), 7.68-7.65 (m, 4H, Ar), 7.41-7.34 (m, 6H,

= 7.9,2H, Ar), 6.46 (d,

= 2.9 Hz, IH, HI), 4.93 (t, J = 2.6 Hz, IH,

772), 4.85 (br, IH, 773), 4.68 (br, IH, H4), 3.99-3.94 (m, 2H, 775), 2.40 (s, 3H, Ar-CHs),
1.05 (s, 9H, C(CH3) 3 ). l^C NMR (50 MHz, CDCI3) 8 165.27 (C(O)-Ar), 149.14 (Cl),
143.74 (C(0)-Ar), 135.74,134.94, 129.92,129.81,129.25,129.04,127.84,127.70
(Ar), 127.02 (Ar-CH3), 103.46 (C2), 86.36 (C3) 77.22 (C4), 64.06 (C5), 26.86
(C(CH3)3), 19.04 (C(CH3)3). Anal. Calcd for Cz9H3z04Si: C 73.70, H 6.83. Found: C
73.82, H 6.63.
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Synthesis of l,4-Anhydro>3-0-(/erf-balyldlniethylsiIyI)-2-deoxy-D-«yl‘A/’opent-l-enitol (2n).36
Prepared according to Method D from In (0.1607 g, 0.45 mmol) and (NH4>2S04
(0.304 g, 2.30 mmol). Alumina flash chromatography yielded a yellow oil (0.0375 g,
36%). TLC: Rf 0.76 (1:2 EtOAc-hexanes).

NMR (200 MHz, CDCI3) 5 6.47 (dd,

Jh2 = 2.5 Hz, IH, H l\ 5.01 (t, J= 2.5 Hz, IH, H 2\ 4.81 (t,7 = 2.3, IH, H3), 4.30 (dt, J
= 2.7,9.1 Hz, IH ,7/4),3.65(dd,7H4 = 6.3, 7H5= 10.7Hz, lH ,/fJ),3.4 4 (dd,7H4= 6.6,
7h5 = 10.7 Hz, IH, H5), 0.89 (s, 9H, C(C% )j), 0.13 (s, 6H, S1-CH3).

NMR (50

MHz, C D C I3 ) S 148.87 (Cl), 103.38 (C2), 88.84 (C3), 76.09 (C4), 62.16 (C5), 25.89
(C (C H 3 )3 ) ,

18.13 (C(CH3)3), -4.33 (Si-CHs).

2,5.26 Synthesis of l,4-Anhydro-3-0-(ISert-baty!diphenybilyi)-2-deoxy-D-eiytftropent-l-enitol (2o).24’^5
Prepared according to Method D from lo (0.180 g, 0.37 mmol) and (NH4)2S04
(0.245 g, 1.86 mmol). The product was purified using alumina flash chromatography to
yield a yellow oil (0.105 g, 79%). TLC: 7^0.90 (1:2 EtOAc-hexanes); *H NMR (250
MHz, C D C I3 ) 5 7.76-7.66 (m, 4H, A r\ 7.46-7.38 (m, 6H, Ar), 6.45 (d, 7h2 = 2.5 Hz, IH,
7/7), 4.87 (t,7 = 2.7 Hz, IH, 7/2), 4.78 (t, 7 = 2.5, IH, 7/i), 4.53-4.47 (m, IH, 7/4), 3.41
(dd,7H4 = 7.0,7h5 = 10.8 Hz, IH, 7/5), 3.26 (dd,7H4 = 5.1,7hs = 10.8 Hz, IH, 7/5), 1.10
(s, 9H, C(CHs)3). 13c NMR (50 MHz, CDCI3) 5 148.96 (Cl), 135.80,135.24, 134.23,
129.63,127.70 (Ar), 103.33 (C2), 89.14 (C3), 76.37 (C4), 62.40 (C5), 26.57 (C(CH3)3),
19.02 (C(CH3)3).
2.6 References
(1)

Daves, G. D., Jr.; Cheng, C.C. Prog. Med. Chem 1976,13,303-349.

(2)

Hacksell, U.; Daves, G. D., Jr. Prog. Med Chem. 1985,22,1-65.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

39

(3)

Schweitzer, B. A.; Kool, E. T. J. Org. Chem. 1994,59,7238-7242.

(4)

Schweitzer, B. A.; Kool, E.T. J. Am. Chem. Soc. 1995,117,1863-1872.

(5)

Ren, R. X.-F.; Chaudhuri, N. C.; Paris, P. L.; Runmey, S.; Kool, E. T. J.
Am. Chem. Soc. 1996, 118,7671-7678.

(6)

Moran, S.; Ren, R. X.-F.; Runmey, S.; Kool, E. T. J. Am. Chem. Soc. 1997,
119,2056-2057.

(7)

Hildbrand, S.; Leumann, C. Angew. Chem. Int. Ed. Engl. 1996, 35, 19681970.

(8)

Watanabe, K. A. Chemistry o f Nucleosides and Nucleotides', Plenum Press:
New York, 1994; Vol. 3.

(9)

Solomon, M. S.; Hopkins, P.B. Tetrahedron Lett. 1991,32, 3297-3300.

(10)

Jaramillo, C.; Knapp, S. Synthesis 1994, 1-20.

(11)

Kraus, G. A.; Molina, M. T. J. Org. Chem. 1988,53, 752-753.

(12)

Arai, I.; Daves, G. D., Jr. J. Org. Chem. 1978,43,4110-4112.

(13)

Arai, I.; Daves, G. D., Jr. J. Org. Chem. 1979, 44,21-22.

(14)

Daves, G. D., Jr. Acc. Chem. Res. 1990, 23,201-206.

(15)

Kwok, D.-L; Farr, R. N.; Daves, G. D., Jr. J. Org. Chem. 1991, 56, 37113713.

(16)

Zhang, H.; Brakta, M.; Daves, G. D., Jr. Nucleosides Nucleotides 1995,14,
105-116.

(17)

Chen, J. J.; Walker, J. A.; Liu, W.; Wise, D. S.; Townsend, L. B.
Tetrahedron Lett. 1995,36, 8363-8366.

(18)

Erion, M. D.; Rydzewski, R. M. Nucleosides Nucleotides 1997, 16, 315337.

(19) Sharma, M.; Brown, R. K. Can. J. Chem 1966, 44,2825-2835.
(20) Ferrier, R. J. Adv. Carbohydr. Chem 1969,2 4 ,199-266.
(21)

Ireland, R. E.; Thairisvongs, S., Vanier, D.; Wilcox, C. S. J. Org. Chem.
1980, 45,48-61.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

40

(22)

Cheng, J. C.; HackseU, U.; Daves, G. D., Jr. J. Org. Chem. 1985,50,27782780.

(23)

Kassou, M.; Castiilon, S. Tetrahedron Lett. 1994,35, 5513-5516.

(24)

Walker, J. A.; Chen, J. J.; Wise, D. S.; Townsend, L. B. J. Org. Chem.
1996,61,2219-2221.

(25)

Larsen, E.; Jorgensen, P.T.; Sofan, M. A.; Pedersen, E. B. Synthesis 1994,
1037-1038.

(26)

Free thymidine (la) and toluoyl protected thymidines (Id, Ig, li, Ik-m )
are much less soluble in HMDS, and dissolve slowly in refluxing HMDS.

(27) For example, attempted preparation of 2k by Method D resulted in the
formation of the TBDPS ether of furfuryl alcohol: *H NMR(200 MHz,
CDCb) 5 7.65-7.61 (m, 4H, Ar), 7.38-7.26 (m, 6H, Ar), 6.21 (m, IH, H2),
6.06 (d, IH, H3), 2.18 (s, 2H, H5), 0.99 (s, 9H, C(CH3>3). ‘^C NMR (50
MHz, CDCb) 5 142.06 (Cl), 110.15 (C2), 107.35 (C3), 58.92 (C5), 26.80
(C(CH3)3), 14.18 (C(CH3)3).
(28) Perbost, M.; Hoshiko, T.; Morvan, F.; Swayze, E.; Griffey, R. H.; Sanghvi,
Y. S.y. Org. Chem. 1995,60, 5150-5156.
(29) OgUvie, K. K. Can. J. Chem. 1973,51,3799-3807.
(30)

Bou, V.; Vilarrasa, J. Tetrahedron Lett. 1990,31, 567-568.

(31)

Mitsunobu, O.; Kimura, J.; Fujisawa, Y., , Bull. Chem. Soc. Japan 1972,
45,245-247.

(32)

Matulic-Adamic, J.; Watanabe, K. A. Chem. Pharm. Bull. 1988, 36, 15541557.

(33)

Shinozuka, K.; Hirota, Y.; Morita, T.; Sawai, H. Heterocycles 1992, 34,
2117-2121.

(34)

Lipshutz, B. H.; Hayakawa, H.; Kato, K.; Lowe, R. F.; Stevens, K. L.
Synthesis 1994,1476-1484.

(35)

Farr, R. N.; Daves, G. D. J. Carbof^dr. Chenu 1990, 9 ,653-660.

(36)

Gold, B. I. PCT InL Appl. W09623777 8 Aug. 1996, see Chem. Abstr.
125:248328

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Chapter 3
Synthesis of C-Nucleosides

3.1 Introduction
Universal nucleosides have been of great interest recently because of their ability
to pair with any of the four naturally occurring nucleosides. This allows them to be
inserted into ambiguous positions in DNA templates or primers. Through the use of
variable hydrogen bonding patterns or relying solely on base stacking interactions, they
can impart a greater stability to a DNA duplex than can be achieved by normal base pair
mismatches.
One use of universal nucleosides is in the ambiguous third position of DNA
primers. Primers are necessary in extension reactions such as Polymerase Chain
Reactions (PGR) and Sanger dideoxysequencing. In these reactions, the DNA strand of
interest (to copy or to sequence) is called the template. To this template, the primer, a
short section of DNA complementary to the template, is hybridized. Using the primer,
an entire strand of DNA, complementary to the template, can be generated via PCR.^
Using the same type of extension reactions, while providing a portion of
dideoxynucleotides, generates DNA strands with a variety of lengths. When the
difference in length is one base, the identity of that base can be disclosed by gel
separation.4'5
In order to utilize any of these types of extension reactions, a primer
complementary to the template must be generated, therefore, the sequence of the portion
of the template where the primer will be attached must be known. This can be
41
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determined by sequencing the encoded protein. A group of three nucleotides (a codon)
codes for the production of a specific amino acid in a protein. However, each amino
acid can be generated by several different codons which generally differ in the third
position.^ This can be seen in Figure 3.1. The question maries are the unknown
positions and the Xs are the universal bases that are incorporated into the primer versus
the ambiguous positions. Thus the sequence of the primer is ambiguous in every third
position, but a universal nucleotide can be inserted into the ambiguous positions. ^^

X
5» - G G

9

A T

9

G T

9

T X G T X
G A 9 C A 9 - 3’
c

Figure 3.1. Diagram of the use of universal bases in ambiguous positions in
primers.
Another use of modified nucleotides is in the detection of minute amounts (1 in
10^ of point mutations in gene sequences (Figure 3.2). To accomplish this, normal
DNA corresponding to the mutation is converted to a restriction enzyme site. After
PCR amplification,^ digestion with the restriction enzyme removes the modified normal
strand thereby selectively enhancing the mutant sequence.^ Conversion of the normal
strand to a restriction site is accomplish through the use of base transposing agents.
These agents are modified nucleotides that pair to one or more of the natural
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Figure 3.2 Amplification of mutant DNA using PCR and restriction endonucleases
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rounds of PCR as demonstrated in Figure 3% In this example, the normal to mutant
strands start out in a one to one ratio. They are first denatured and a primer is attached
(Figure 3.2, step 1). Both of the primers o f the contain a base transposing agent on the
3' end. The primers are extended with a polymerase agent (Figure 3.2, step 2). In this
example the base transposing agent is designed to insert an “A” across fium it in the
PCR process. The duplexes are again denatured (Figure 3.2 step 3), and a primer is
attached to the newly made strand. The primer is again extended with a polymerase
agent (Figure 3.2, step 4). The duplexes are now in a two to two ratio (the original
strands and modified strands are counted together). The entire process is repeated
(Figure 3.2, step 4) to give a three to three ratio. The duplexes are subjected to a
restriction engine partial to the normal strands (Figure 3.2, step 5). The normal strands
are removed leaving the mutant to normal in a three to one ratio.
3,2 Specific Proposal
The preparation of C-nucleosides is of intense interest because of their potential
anti-viral and anti-tumor activity^» ^0 and their use as novel base pairing moieties in
oligonucleotides. 11-14 jh e nucleoside analogue 5-(2'-deoxy-|3-D-ribofuranosyl)-2hydroxypyrimidone (Figure 3.3,1) is o f additional interest because it is a C-nucleoside,
meaning the bond firom the sugar to the base is a C-C bond rather then a C-N bond.
This nucleoside was designed to fimction as a base transposing agent. The base could
potentially exist in two tautomers as shown in Figure 3.3. Depending on the tautomer
the hydrogen bonding pattern of the modified nucleoside could mimic a T or a C. This
could allow it to fimction as a base transposing agent
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OH

NH
HO

HO

Figure 33. Target C-nucIeoside
The approach we chose was based on the path advocated by Daves et a/. ^8-23
For this method the pyrimidone nucleoside 1 is generated by Pd(0) coupling of an
iodinated pyrimidone ring to a silyl protected glycal (Scheme 3.1 ) followed by
deprotection with tetrabutylammonium fluoride and treatment with sodium
triacetoxyborohydride in acetic acid.

RO^

O
U

_
'

N
/ / + (I
OR'

VI

N^NH
NH
J

p.
™

o T
Y 7

tetrabutyl
hO- ^
ammonium flouride
►
\

/

.
triacetoxybo^ydride 1
inacedcacid

Scheme 3.1 Proposed synthesis of 5-(2'-deoxy-P-D>ribofaranosyl)-2hydroxypyrimldone
3 3 Coupling reactions
In addition to generating the glycal (described in Chapter 2), the synthesis of 5iodopyrimidone (Scheme 3.2) was required for the palladium coupling reaction. This
was accomplished by generating 2-hydroxypyrimidine hydrochloride (2) by the known
method of treating urea and tetramethoxypropane with HCl in dry methanol (HCl,
CH3OH, reflux, Ih. (78%)).24 It was converted to 5-iodopyrimidone (3) by iodination
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Scheme 3^ Synthesis of S-iodopyrimidone
with A^-iodosuccinimide in the absence of light and moisture (iV-iodosuccinimide in
DMF, dark, room temperature, 24 hs. (82%)).25
The coupling reaction of 5-iodopyrimidone (3) to a variety of glycals (Scheme
3.1) was tried utilizing a variety of conditions. The Pd(0) was generated in situ from
Pd(0 Ac)2 using tri-iV-butylamine or added as Pd(0) attached to a resin. The coupling
was attempted in the presence and the absence of a ligand (triphenylarsine) with the
Pd(OAc)z being complexed to the ligand prior to reaction in some cases. It was also
once attempted in the presence of sodium acetate. In all cases the solvent was DMF,
and the reaction was heated to 75-I00‘’C. A coupling of the base to dihydropyran was
attempted as a control with similar varieties of conditions. In all cases no product was
formed. However the coupling of bromobenzene to dihydropyran worked well. Daves
et

then reported that coupling reactions were found to fail in the presence of an

amide. To compensate for this, 5-iodopyrimidone (3) was protected with a TMS group
or a dihydropyran group. Again a variety of coupling conditions were utilized but no
product was generated. The TMS group speared unstable and the dihydropyran group
created added difficulty in characterization. 5-Iodopyrimidone was then converted to 5iodo-2-methoxypyrimidine (64%) by treatment with phosphorus oxychloride (Scheme
3.3) and diethylaniline at reflux for 24 hours to yield 5-iodo-2-chloropyrimidine (4) in
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63% yield. This was immediately treated with sodium methoxide as shown in Scheme
3.3 (Na, CH3OH, room temperature, 2 h (5 ,95%)).22 The coupling reaction was tried
utilizing the protected pyrimidine 5 under a variety of conditions. Pd(OAc)2 was again
Cl

_

Phosphorous oxychloride
dietlQrIaniline

N '^ N

sodium methoxide

N ^ N
^

I

I

4

5

Scheme 33 Conversion of 5-modopyrhnidone to 5-iodo-2-methoxypyrimldlne
used as the Pd(0) source but it was reduced using triethylamine. Occasionally sodium
hydrogen carbonate was added to the mixture. The coupling was attempted several
times without ligand using DMF or acetonitrile as the solvent. It was also attempted
with PPhs (attached to a resin) as the ligand. Again, all attempts failed.
Coleman ef a/. 26 recently published the synthesis of a C-nucleoside using a
palladium-catalyzed Heck coupling strategy. In this publication th^r report many of the
same problems we encountered. There does not seem to be a standard set of reaction
conditions for this type of reaction, or even for a particular group of compounds used in
this reaction. Many different reaction conditions have to be varied (choice of ligand,
solvent, base, choice of glycal, source of palladium) in the hopes of determining a set of
conditions that would promote the reaction. Some conditions that we found to be
ineffective were also found to be ineffective by Coleman et al. 26 Although the reaction
theoretically needs 0.1 equivalent of palladium it seems to progress better with 0.5
equivalents. The use of triethylamine as the base is often ineffective and should be
replaced with sodium hydrogen carbonate.
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One reason for the failure was thought to be that 5-iodo-2-methoxypyrimidine
(5) was too reactive, because the main products formed seemed to be reduction of the
pyrimidine and dimers of pyrimidines. This indicated we were forming the requisite
insertion of palladium into the Ar-I bond but the reaction was proceeding on along an
unproductive pathway. Therefore 5-bromo-2-methoxypyrimidine was tried instead. It
was ^thesized by treating 2-hydroxypyrmidinone (Scheme 3.4,2) with Brz in water at
room temperature for 24 hours giving 5-bromopyrimidone (6) in 55% yield. This was
o
^

2

Brz/HjO

n^

»
nH

^

Phosphorous oxycfaloride
diethylaniline

^
6

N

^
N

sodium methoxide

N
^

Br

Br

7

8

Scheme 3.4 Synthesis of 5-bromo-2-methoxypyriniidlne
then converted to 5-bromo-2-chloropyrimidine (7, 70%) and then to 5-bromo-2methoxypyrimidine (8, 95%) using the same method described above. The coupling
reactions were tried again without success.
Cabri et alX^ reported the possibility of mechanisms based on two reaction
pathways (Scheme 3.5) which were supported by the results of Coleman et
Pathway A involves coordination of the olefin via the dissociation of one neutral ligand.
This is the pathway followed by reactions involving aryl halides. Historically this was
the proposed form of the reaction. A modification of the reaction, using triflate as the
leaving group changes the pathway to B. In this pathway the coordination of the olefin
proceeds via dissociation o f the anionic ligand because o f the very weak nucleophilici^
of triflate. Therefore, pathway B is promoted by the use o f bidentate ligands such as
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Scheme 3^ Pd coupling mechanism proposed by Cabri
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l^-bis(diphenylphosphino)propane (DPPP) whereas path A is slowed. In addition
pathway B is better for electron rich double bonds. Therefore, a possibility is the use of
5-trifIate-2-niethoxypyriinidine with DPPP as the ligand.
Another reason for difficulty is that the glycals are rather unstable, and are
possibly being destroyed under the reaction conditions. However 5-0-toluoylglyca!s
tend to be rather more stable than silyl protected glycals, but coupling reactions utilizing
these compounds were also unsuccessful.
3.4 Grignard Reactions
In light of the above results, preparation o f the pyrimidone nucleoside 1 was
attempted by Grignard reaction as demonstrated by Kool et

in this method 1-

chloro-2-deoxy-3,5-di-0 -/7-toluoyI-a-D-e7yrhro-pentosyI chloride is required rather then
a glycal.

It

is synthesized by the known literature p r e p a r a t i o n ^ ^ of treating 2-

deoxyribose (Scheme3.6,9) with HCl in methanol followed by protection withp-toluoyl
TolO^

\

y

r r

I. HCl in_methanol_________ ^
2. p-toluoylchloride in pyridine

TolO^

Q

^ '^ O M e
yJ
“

Acetic Acid

^

\_ /c i

„

5 tôI
10

Scheme 3.6 Synthesis o f 33-^bistoIaoyl-l-chlororibose

chloride in pyridine to give the 3,5-D-bistoluoylprotected sugar (Scheme 3.6,10,99%).
The methoxy group is then exchanged for a chlorine using HCl in acetic acid to yield
the 3,5-O-bistoluoyl-l -chlororibose (11,60%).
S-Iodo-2-methoxypyrimidine (3) and 5-bromo-2-methoxypyrimidine (8) were
converted to the Grignard by treatment with magnesium and iodine in tetrahydrofuran

Reproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

51

(Scheme 3.7).^ The chlorosugar 11 was then added, and the solution was stirred
overnight. The reaction was also tried with the addition of one equivalent of copper,
OMe
OCH,

MgX

li

I

OTol

Scheme 3.7 Grignard coupling o f S-iodo-2-metho^q*yrim:dine to chlorosugar

but all attempts were unsuccessful. The major product appeared to be (by NMR) the
addition of the pyrimidine to the toluoyl protecting group.
3.5 Conclusions

Synthesis of the C-nucleoside 5-(2'-deoxy-P-D-ribofuranosyl)-2hydroxypyrimidine has been hampered by a number of synthetic hurdles. The starting
materials were difScult to prepare and were often stable for only short periods of time.
In addition both the Pd coupling procedure and the Grignard procedure yielded reaction
mixtures that were a complex mixture of numerous products. Traces of the desired
product were occasionally seen, but it was never isolated. One problem is the
possibility that the product is acid labile and does not survive the isolation techniques.
The nucleoside is unlikely to be generated by a coupling procedure that unites a pre
formed sugar system to a base, however it is being investigated by the method of
construction of the base on the sugar.
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3.6 Experimental
3.6.1 Synthesis o f 2-Hydroxypyrimidiae Hydrochloride (2).24

A 3 liter flask was charged with one liter o f dry methanol (791 g, 24.68 mol).
The methanol was saturated with HCl by bubbling gas through it for 20 minutes at 0°C.
Urea (182.34 g, 3.04 mol) was dissolved in the solution and then 1,13,3-tetra
methoxypropane was added dropwise. The mixture was warmed to room temperature
and then refluxed for one hour. Yellow crystals formed and were filtered and dried over
NaOH in vacuo. Yield was 312.50 grams (78%). EIMS 97.1 (M + H)+; IR NMR (300
MHz, DMSO) 8 14.14 (b, IH, NH), 8.79 (d, IH, H4 or H6 , J hs= 5 . 8 ) , 6.82 (t, IH, H5.
J h 4 = 5 .8 0 ) .

13c

NMR (75 MHz, DMSO) 8 159.32 (C4, C6), 147.99 (C2), 104.30 (05).

3.6.2 Synthesis o f 5-Iodopyrimidone (3).^^

2-Hydroxypyrimidine hydrochloride (11.98 g, 0.09 mol) was introduced to a
dried flask under Ar. DMF (80 mL) was added and the flask was wrapped in aluminum
foil to exclude light. N-iodosuccinimide (20.09 g) was added and the solution was
stirred for 24 hours. The DMF was removed under vacuum and the solid was washed
with ether and then with acetone to yield 16.52 grams (82% yield) o f a bright yellow
solid. m.p. 240 ®C, EIMS 220.9 (M-H)', ‘H NMR (250 MHz, DMSO) 8 12.15 (b, IH,
NH), 8.45 (s, 2H, H4 andH 6 ). "C NMR (62.5 MHz, DMSO) 161.57 (C2), 155.83 (C4
and C6), 85.53 (C5).
3.6.3 Synthesis o f 2-Chloro-5-Iodopyrimidine(4).^^

A dried flask was charged with 5-iodopyrimidin-2-one (1.58 g, 7.11 mmol).
Phosphorus oxychloride (10 mL) was added and then diethylaniline was added slowly.
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The solution was refluxed for 12 hours. It was cooled to room temperature and poured
over ice (300 mL) and left for 15 minutes. The product was extracted with ether (3x 75
mL) and washed with saturated aqueous NaHCCh and then with distilled water. The
ether layer was dried with sodium sulfate and the solvent was removed under reduced
pressure to yield 1.15 grams of oil (63% yield). EIMS 240.9 (M+H)^;

NMR (250

MHz, CDCI3) 6 8.81 (s, H4 and H 6 ).
3.6.4 Synthesis of S-Iodo-l-methoxypyrimidine (5).^^
2-Chloro-5-Iodopyrimidine (1.05 g, 4.4 mmol) was added to a dried flask. Dry
methanol (4.5 mL) was added to the flask. Sodium metal (0.17g, 7.39 mmol) was
dissolved in 5.5 mL of dry methanol and the solution was added dropwise to the 2~
Chloro-5-Iodopyrimidine solution. The solution was allowed to stir for two hours and
then the methanol was evaporated under reduced pressure. The product was partitioned
between water and chloroform. The chloroform layer was dried with sodium sulfate,
partially evaporated and recrystallized yielding 0.983 g of product (95% yield). Rf=
0.64 (1:2 ether/hexanes). 'H NMR (250 MHz, CDCI3) Ô8.65 (s, 2H, H4 cmdH6 ), 3.99
(s, 3H, OC//3). '^C NMR (75 MHz, CDCI3) Ô 164.07 (C2 and C4), 55.11 (OCH3).
3.6.5 Synthesis of S-Bromopyrimidone (6).^^
Distilled water (300 mL) was added to a liter flask. Bromine was added (0.435
mL) and the solution was stirred until it was evenly distributed. 2-Hydroxypyrimidine
hydrochloride (1.0064 g, 7.6 mmol) was added and the solution was left to stir for 24
hours. The solution was periodically checked by NMR and more Brz was added as
needed to drive the reaction to product (0.91 mL additional Br; was added). The water
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was driven off and the product recrystallized firom ethanol to yield 0.7288 g (55% yield).
‘H NMR (200 MHz, DMSO) Ô 8.21 (s, H4 and H 6 ).
3.6.6 Synthesis of 5-Bromo-2-methoxypyrimldme (8).^^

5-Bromo-2-chloropyrimidine (3.3811 g, 19.32 mmol) was added to a dried flask
followed by POCI3 (20 mL). Diethylaniline was added (1 mL) and the solution was
refluxed for 12 hours. It was then cooled to 0°C and quenched by pouring it onto ice.
The product was extracted with dichloromethane. The organic layer was washed with
NaHCO] until bubbling stopped. It was then washed with saturated brine and distilled
water. It was dried with NazSO# and evaporated under reduced pressure to yield a
yellowish syrup (3.63 g, 12.74 mmol) in 70 % yield. The 5-bromo-2-chloropyrimidine
(7) was then dried under high vacuum and dissolved in dry methanol (30 mL). Another
20 mL of dry methanol was added to an addition funnel and sodium metal was added
(0.3 8g, 16.53 mmol). When it had reacted the solution was added dropwise. NMR on
an aliquot showed reaction had not finished after several hours so 10 mL of CH3OH and
0.2 g of sodium were added to the addition funnel and then dropped into the solution.
The solution was left to stir for 2 hours and then the methanol was removed under
reduced pressure. The product was extracted firom water with ether. The organic layer
was washed with saturated NaHC03 and distilled water. The ether was partially
evaporated under reduced pressure and the product was recystallized to yield 0.5149 g
(3.198 mmol). *H NMR (250 MHz, CDCI3) 5 8.35 (s, 2H, H4 andH 6 ), 4.02 (s, 3H,
OCH3).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

55

3.6.7 Synthesis of l-M ethoxy-2^bis-0-tolaoylribose (10).^^

2-Deoxyribose (13.6 g, 0.1 mol) was dissolved in dry methanol (240 mL). A
solution of 1% HCl in CH3OH was added and the solution was stirred for 15 minutes.
Silver carbonate (3.5 g, 12.69 mmol) was added quickly with vigorous stirring for 5
minutes. The mixture was filtered and the resulting clear solution was evaporated under
reduced pressure to give a clear syrup. Residual methanol was removed by coev^x>ration with pyridine. The syrup was then dissolved in dry pyridine (100 mL) and
cooled to 0®C. p-Toluoyl chloride (34g, 022 mol) was added dropwise over 2 hours.
The solution was allowed to warm to room temperature and stirred under nitrogen
overnight. Distilled water was added (300 mL) and the product was extracted with ether
(3 X200 mL). The organic layer was washed with distilled water, 2N H2SO4 and
saturated KHCO3. It was dried with Na2S04 and evaporated under reduced pressure to
give a yellow syrup (38.3 g, 0.099 mol) in 99% yield.

NMR (300 Mhz, CDCI3) 5

7.95 (m, 2H, Ar), 7.29 (m, 2H, Ar), 5.60 (m, 2H, H2), 5.40 (m, 1 H, H2), 5.19 (m, 2H,
HlandH4), 4.54 (m, 2H, H5), 3.42 (s, 3H, OC//3), 2.39 (s, 6H, CH3).
3.6.8 Synthesis o f l-C hloro-3^bis-0-tolaoylribose (11).

1-Methoxy-3,5-bis-O-toluoylribose (4.11 g, 0.011 mmol) was dried in a flask
under high vacuum for 8 hours. Cool glacial acetic acid (5 mL) was added. The
reaction was kept at 10®C and HCl saturated acetic acid (8.8 mL) was added. HCl gas
was then bubbled through until a white precipitate started to form. It was stirred for 5
more minutes and then it was filtered, washed with dry ether and dried in vacuo over
P 2O 5.

The yield was 2.498 g of a white solid (60 %). *H NMR (250 MHz, CDCI3) 6
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7.91 (m, 2H, A r\ 7.25 (m, 2H, Ar), 6.47 (d, IH, H l\ 5.55 (m, IH, H3), 4.85 (m, 2H,
H2), 4.63 (m, 3H, H4 ondHS), 2.42 (s, 3H, C/fj), 2.41 (s, 3H, C/fj).
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Chapter 4
Non-Hydrogen-Bonding Nncleobase Analogs: Synthesis and Thermo<tynaniic
Analysû o f Ol^onncleotides Containing 4-Snbstitated-PyrazoIe Nucleotides

4.1 Introduction

The thermo(fynamic stability of the DNA double helix has been under intense
investigation since its discovery by Watson and Crick in 1953. ^ The relative
importance of interactions giving rise to that stability such as, base-base hydrogen
bonding, “base stacking” and base pair geometry has been the subject of much research.
However, the relative importance of each contribution is not fully understood. It is
gmerally accepted that H-bonds between DNA molecules in aqueous environments can
only partially account for duplex stabilization because of high dielectric constants of the
medium and competition for H-bonding with s o l v e n t . 2 > 3 Thus, the contribution to the
duplex stability from “base-stacking” (the interaction between aromatic tc systems) may
be roughly the same as from hydrogen bonding. It is estimated that base stacking and H
bonding both contribute approximately 1 kcal/mol of free energy to the stability of the
base pair.^’^ It has been observed that free mononucleotides in aqueous solution tend to
aggregate without hydrogen bonding (according to NMR). Consequently base stacking
in DNA has become an area of much interest. However, there have been few studies to
determine the factors contributing to 7C-ir interactions in the DNA structure.^ Theoretical
studies have identified several contributing factors: solvophobic effects,^»^ van der
Waals f o r c e s ^ - 10 and electrostatic e f f e c t s . ^ 1

2

Experimental studies that aid in

5 8
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determining the importance of each component would be useful in their own right and
would aid in the design o f biologically important molecules.
One way to investigate this is to incorporate non-hydrogen bonding nucleosides
into a DNA double helix and determine the effect on the thermodynamic parameters.
There have been several non-hydrogen bonding nucleosides incorporated into
d u p le x e s ,

13-18 however, one o f the first examples of a series of non-hydrogen bonding

nucleosides used to study base stacking experimentally was performed by Kool and
coworkers. 1^ Following the work of Turner et al.^ they placed a series o f modified
nucleosides in a d angling position of a duplex to determine the effect on stability. The
series of nucleosides ranged in size and polarity and were put on the end of a DNA
duplex in a position that had no base pairing partner (5’-XCGCGCG-3’ was used as a
self complementary strand where the modified bases (X) dangled off both ends without
a pairing partner). They found that the nucleoside analogs that were larger and less
polar increased the Tm the most.
Bergstrom et a/.20 investigated the importance of “base-stacking” by placing a
series of nitrosubstitued azoles as well as some non-nitro containing controls into the
core of a DNA duplex. They discovered that the role of the nitro group was extremely
important in stabilization. They also discovered that a ring nitrogen capable of
hydrogen bonding decreased the “universality” o f the nucleoside.
4,2 Design of Nacleosides
In an effort to determine the effect different sizes, stacking abilities and charge
profiles would have on the stability of nucleosides we have synthesized and determined
the thermodynamic properties o f a series of non-hydrogen bonding nucleosides:
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l-(2’-<ieoxy-P-D-ribo£uranosyl)-4-iodopyrazoIe (Figure 4.1, a), l-(2’-deo3qr-P-Dribofiiranosyl)-4-nitropyrazoie (Figure 4.1, b), l-(2’-deoxy-P-D-ribofiiranosyl)-4propynylpyrazole (Figure 4.1, c), l-(2’-deoxy-P-D-ribofuranosyI)-4-(2-thia2oIyl)
pyrazole[l-(2’-deoxy-P-D-ribofiiranosyl), [l-(2-deoxy-P-D-ribofuranosyl), #18] (Figure
4.1, d).
N =n

W
OH
a
b
c
d

X=I
X=N02
X=propyne
X=thiazole

Figure 4.1 Structure of target non-hydrogen bonding nucleosides
Hunter et a/.21 studied the effects caused by sequence on DNA structure.
Because the only difference in the sequence is the bases (the sugar-phosphate backbone
is the same regardless of sequence), the differences must arise from differences in their
interactions. The sequence effects are caused by four Q^ies of interactions; (1) steric
interactions with the guanine amino group in the minor groove,^^ (2) steric interactions
associated with the configuration of the step (interaction of two adjacent bases on a
single DNA strand; purine-purine, purine-pyrimidine or pyriniidine-pyrirnidine),^^ (3)
steric interactions of the thymidine methyl in the major groove, (4) electrostatic
interactions associated with the molecular charge distributions of the A-T and C-G base
pairs. Hunter et a/.^l found that for an AA/TT step the interaction was dominated by
steric interactions because the A-T pair has no large regions of high charge densi^

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

61

(Figure 4J2). The CC/GG step is dominated by electrostatic interactions because of the
regions of high charge density (a center of positive charge over cytosine

±1

I A

R
Figure 4.2 Electronic charge distributions of natural nucleosides
and a negative charge one over guanine). This indicates that when there are large
centers of charge the electrostatic interactions become increasingly more important.
Bergstrom and coworkers^^ studied a series of nitro substituted azoles to
investigate the effect of electronic structure and heterocycle size on duplex stability.
They discovered that the nitro group played an important role in stability, however in
the absence of other groups the exact nature of the role of the substituent could not be
determined. They also discovered that adding a ring nitrogen that could be involved in
hydrogen bonding increased the specificity of the base.
Froehler et. a/.^4,25 found that substituting a propyne substituent onto the C-5
position of cytosine and uridine increased the stability because of entropie factors
caused by the hydrophobic chain displacing water. In addition the propyne unit
probably allowed increased “base-stacking”. Froehler et al.^^ also found that a thiazole
substituent increased the stability of a dC or a dG. The thiazoyl substituent was
postulated to be planar with the heterocycle and to allow a larger area of delocalized tc
electrons which would aid in base stacking.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

62

The pyrazole ring was chosen because utilizing a small ring size would
decrease the likelihood of steric hindrance when placed versus one o f the purines.
Bergstrom and coworkers^^»^^ synthesized one of the first non-hydrogen bonding
nucleoside analogs that possessed some degree of stability, 3-nitropyrrole. The molecule
was designed to mimic the electronic configuration ofp-nitroaniline, a know DNA
intercalator and to be small enough to be incorporated versus purines without disrupting
H-bonding. Kool and cowoikers^^ also showed that breaking the hydrogen bonding of
the nucleoside to solvent without replacing it with anything was thermodynamically
unfavorable. Utilizing a smaller ring size would allow the incorporation of solvent
molecules more easily if necessary. The use of iodo, nitro, propynyl and thiazolyl
substituents would allow a variation in size and electronic charge distribution profile
(Figure 4.3) that would lend insight into the roles they play in thermodynamic stability.
The calculations were made using Huckel molecular orbital calculation in the Sybyl
molecular modeling program.
Generally a broader tc cloud and one that has centers of charge or is relatively
polarizable increases stacking. This would indicate that as the substituent on a

.009
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Figure 4 3 Electronic charge distribution of bases
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heterocycle is changed from an iodo through nitro and propyne to a thiazoyl there would
be an increase in the binding afBnhy in a duplex and therefore an increase in Tm.
4 ^ Synthesis of Nacleosides
4-Iodopyrazole nucleoside, 4-bromopyrazole nucleoside and 4-nitropyrazole
nucleoside (2a-c) were synthesized by treating the appropriate pyrazole (4-iodopyrazole
la , 4-bomopyrazole lb or 4-nitropyrazole Ic) with NaH and then adding it to 3,5-BisO-^toluoyl-1 - c h l o r o - p - D

- r ib o s e 2 0 * 2 7 ,2 8

in 7 2 % to 86% yields (Scheme 4.1). 4-

iodopyrazole is commercially available but 4-nitropyrazole and 4-bromopyrazole were
X
X

I. NaH

// 'I,N

.

//

2. ToIO

1 o

! >\ =/ Y ,

H

laX=r
Ib X=Br
1cX=N02

ToIO

V

T d O -. ." N '"
V —/
P

EtaN

Çu|

ToIO—I

Pd(Cl2XPPh3)2

ToIO

ToIO

2aX =l
2b X=Br
2c X=N02

2d

Scheme 4.1 Synthesis of pyrazole nucleosides
synthesized from pyrazole using fuming nitric acid/fuming sulfuric acid or bromine in
water respectively. 4-Propynepyrazole nucleoside (2d) was made from 4-iodopyrazole
nucleoside or 4-bromopyrazolenucleoside (2a or 2b) by treatment with propyne gas,
Pd(Cl2)(PPh3)4,29,30 triethylamine and copper iodide in 96 % yield.
The toluoyl protected nucleosides (2a, c-e) were then deprotected by treatment
with ammonia in methanol to give the 5'- and 3' free hydroxyls (Scheme 4.2,3a,c-e). A
dimethoxytrityl (DMT) protecting group was introduced to the 5'- hydroxyl using
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ToIO

NH3 In CH3OH

DMT-CI

DMTO

DIEA DMAP

CH2CI2
2aX = I
2cX = N02
2dX = Propyne
2e X= Thiazole

4aX = I
4c X= N02
4d X = Propyne
4e X= Thiazole

3aX = I
3cX = NO,
3d X = Propyne
3e X= Thiazole

Cl

V 'O

sOn

DIEA
pyridine

DMTO

ON

5aX = I
5c X = N02
5d X = Propyne
5e X= Thiazole

Scheme 4.2 Conversion of pyrazole nucleosides to phosphoramidites
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diisopropylethylamine (DEEA), dimethylaminopyrinde (DMAP) and DMT-chloride in
dichloromethane to give 4a,c-e. The nucleosides were then converted to the
phosphoramidites (5a,c-e) by treatment with 2-cyanoethyl N ^ diisopropylchlorophosphoramidite in pyridine and DIEA.^ ^ The phosphoramidites
were then incorporated into oligomers using standard solid phase chemistry.
4.4 Solid Phase DNA Synthesis
DNA synthesis is simple in concept A reactive 3'-phosphorus group of one
nucleoside is coupled to the 5'-hydroxyl of another. Generally this is done using the
phosphoramidite method^^ because of the efiBcient and rapid coupling and the stability
of the starting materials. It is usually performed on a solid support^^ (o minimize
isolation and purification steps. An excess of reagents can be used and the product
purified by filtration. The solid support is a controlled-pore-glass (CFG) bead.^^ The
first nucleoside comes attached to the CFG through a succinate ester linkage attached to
a siloxane bond. The rest of the nucleosides are added by a repetition of the series:
detritylation, coupling, coping and oxidation (Scheme 4.3).
The first step in the cycle is the removal of the DMT protecting group from the
5'-hydroxyl (Scheme 4.3, Step 1). This is accomplished using trichloroacetic acid
(TCA). This step is a reversible reaction (under anhydrous conditions) and is driven to
completion by washing away the DMT cation. It yields the free 5'-hydroxyl, which is
ready for coupling to the next phosphoramidite.
The phosphoramidites are protected nucleosides that are ready for solid phase
coupling. They come with 4 protecting groups (Figure 4.4). There is a
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TCA in DCM
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Scheme 4 3 Synthesis o f DNA by the solid phase phosphoramidite method
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HN
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DMTO

O. P-O C H 2CH 2CN

'P-O C H 2C H 2C N
N

Thymidine (T)

Cytidine(C*“ )

DMTI

DMT(

OvP-OCH2CH2CN

'P-OCH2CH2CN

N

Guanine (G"**)

A denosine (A*“ )

Figure 4.4 Protected phosphoramidites
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diisopropylamino on the 3'-trivalent phosphorus group^^ which is used in the coupling
step. There is also a P-cyanoethyl group on the phosphorus which stays in place until
the final deprotection at the end of the synthesis. It helps to prevent side reactions and
aids in solubility. There is a DMT group on the 5 -hydroxyl and benzoyl(bz) or
isobutyryl(ib) on the exocyclic amines of A, C and G. The coupling (Scheme 4.3, Step
2) is accomplished by delivering the phosphoramidite (protected bases are indicated by
B(P)) with the mild acid tetrazole (pKr=4.8). The tetrazole protonates the nitrogen of
the diisopropyl group vdiich is then displaced by the tetrazole.^b This intermediate is
then used to make the intemucleotide phosphite bond with the 5'-hydroxyl.
The third step is capping (Scheme 4.3, Step 3). This step is not strictly essential
but it serves to ease the purification of the final product. The coupling step is not
quantitative. The capping step is used to prevent the unreacted sequences from reacting
in future steps. This helps to keep failure sequences as short as possible which means
they are easier to separate firom the completed product. It is accomplished by treatment
with acetic anhydride and iV-methylimidazole which react to make a powerful acylating
reagent. The last step in the cycle is to oxidize the phosphite triester (trivalent
phosphorus) to a phosphate triester (pentavalent phosphorus) (Scheme 4.3, Step 4).
This is done at the end of each cycle because the phosphite is susceptible to acid and
base cleavage. A mild oxidation is accomplished using iodine in a basic tetrahydrofuran
(THF) solution in water.
After all o f the nucleosides are added, the sequences are cleaved from the
support and the P-cyanoethyl groups on the phosphorus are removed by treatment with
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concentrated ammonium hydroxide at room temperature for 1 hour. The protecting
groups on the exocyclic amines o f the bases are removed by treatment with concentrated
ammonium hydroxide at 5S°C for 8 hours.
4.5 Sequences Used in Thermodynamic Mehing Studies
The four pyrazole nucleosides (3a,c-e) as well as 5-nitroindole for comparison
were incorporated into two sequences. The first was a self-complementary sequence
based on the Dickerson dodecamer (Figure 4.5). The modified oligomers were
incorporated into the fourth position and each of A, C, G and T were incorporated into
the complementary ninth position giving four different modified strands for each
nucleoside analog. In addition four control duplexes were tested to ensure that results
Modified Dickerson Dodecamer

5 -CGC XAA TTY GCG-3’
X= 2a,c-e and 5-nitroindole

Controls

Y= A, C, G and T

5 -CGC AAA TTT GCG-3’
5 -CGC CAA TTG GCG-3’
5’ CGC GAA TTC GCG-3’
5’-CGC TAA TTA GCG-3’

Brown sequence control

5’-CAA AAT GGT GGC CAA GT-3’

Complementary strand

S’-ACT TGG CCA CCA TTT TG-3’

Strands Incorporating Modifications

S’-CAA AAT GGT GGC XAA GT-3’
5’-CAA AAX GGX GGC XAA GT-3’
X= 2a,c-e and 5-nitroindole

Figure 4.5 Sequences used in thermodynamic studies
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were not merely sequence effects. The second sequence was the oligomer used by
Brown in his investigation o f the nitroindole series^ ^ to allow an easier comparison to
5-nitroindole. The same control was used as well as a sequence that incorporates the
modified nucleobases in the thirteenth position fix>m the five prime end. Because a
single modification can easily be accommodated in a DNA duplex a strand was made
that incorporated modifications in the sixth, ninth and thirteenth positions (Figure 4.5).
After purification and analysis (see Experimental) the oligomers were
thermodynamically melted to determine their thermodynamic properties and calculated
Tm at 15 pmol (Tables 4.1 and 4.2).
4.6 Thermodynamic Melting
Thermodynamic melting is the process of denaturing a DNA duplex by heating
it In order to determine the thermodynamic properties of a duplex the absorbance at
260 am is measured as the duplex is heated. As the duplex separates to the single
strands and the bases unstack the absorbance increases in a phenomenon called
hypochromicity. This can be seen in Figure 4.6. When the bases are in a stacked
arrangement the interaction of the electron clouds causes a decreased absorption. This
region is commonly called the “lower baseline”. As they unstack during the melting
process the absorption increases until it reaches the “upper baseline”. The point where
the melting has progressed 50 percent of the way is the melt temperature, Tm. The graph
of the change in temperature versus the change in absorption is called the melting curve.
The thermodynamic results (Table 4.1 and Figure 4.7) show that the series of
pyrazole nucleosides shows a relative increase in thermodynamic stability (based on
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Table 4.1 Thermodynamic results of melting studies on the modified dickerson
dodecamer.
CGCXAATTYGCG
X-Y

T .* C
(IS nm o l)

T-A (Cent 1)

-AT.

AH
(kcal/mol)

AS
(cai/K*mol>

AG
(kcal/mol a t 25*C)

47.5

-72.5

-204

-3.8

G-C(Cont2)

58.8

-99.6

-290.4

-8.1

C-G(Cont3)

54.4

-72.4

-226.3

-4.9

A-T (Cent 4)

53.5

-82.8

-258.8

-5.7

5-mtroindoie-A

25.2

22.3

-39.3

-109.6

-6.6

5-nhroindole-C

30.6

28.2

-26.9

-66.4

-7.1

5-nitroindole-G

27.8

26.6

-29.1

-74.5

-6.9

5-nitroindole-T

38.4

15.1

-36.8

-96.0

-8.1

4-iodopyrazole-A

1 0 .6

3 6 .9

-2 8 .4

-1 0 5 .4

3 .0

4-iodopyrazole-C

3 .2

5 5 .6

-3 3 .7

-1 2 7 .3

4 .2

4-iodopyrazole-G

7 .4

4 7 .0

-2 9 .6

-1 1 1 .1

3 .4

4-iodopyrazole-T

5 .2

4 8 .3

-3 1 .5

-1 3 7 .2

3 .4

4-nitropyrazoIe-A

21.1

26.4

-49.7

-174.2

2.2

4-nitrcpyrazole-C

11.1

47.7

-37.5

-137.2

3.4

4-nitropyrazole-G

10.1

44.3

-33.1

-122.3

3.3

4-nitropyrazoIe-T

14.2

39.3

-37.5

-135.8

3.0

4-propynylpyrazoIe-A

21.9

25.6

-41.4

-145.7

2.0

4-propynyIpyrazoIe-C

5.8

53

-29.2

- 110.1

3.6

4-propynylpyrazoIe-G

18.2

36.2

-53.7

-189.7

2.8

4-propynylpyrazoIe-T

9.3

44.2

-21.1

-80.2

2.8

4-thiazolylpyrazoIe-A

25.2

22.3

-46.2

-132.7

-6.6

4-thiazolylpyrazoIe-C

16.7

42.1

-32.8

-91.0

-5.6

4-thiazoIyIpyrazole-G

27.3

27.1

-34.2

-92.0

-6.8

4-thiazolylpyrazole-T

24.8

28.7

-48.8

-142.0

-6.5
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C o m p a riso n o f -A Tm fo r e a c h a n a lo g w ith
e a c h n a tu ra l b a s e

l«Ai

iaC;

te l
bid

lo

N

Pr

Tz

Figure 4.7 Comparison of ATm for the modified nacleosides with each natural
base
increasing Tm) as the substitutuents vary from iodo to nitro and propyne to thiazole. As
expected the iodopyrazole was the least stable of the pyrazole nucleosides. For the two
incorporations required of a self-complementary strand the stability dropped roughly
20®C-40®C from that of the control. The nitro and propyne pyrazole nucleosides were
more stable than the iodopyrazole but were similar in stability to each other contrary to
expectations. The thiazole pyrazole nucleoside did show a substantial increase in Tm
compared to the other three pyrazole nucleosides. It had a stability approaching that of
5-nitroindole. 5-Nitroindole shows a preference for the pyrimidines (T then C) whereas
the pyrazole nucleosides shows a preference for the purines. For iodo and propyne the
preference was for A over G but thiazole pyrazole showed a preference for G over A
and nitro showed a preference for A then T. It is unlikely that the results are based on
sequence alone because the control sequence with A in the ninth position was the least
stable. The most stable control sequence had C in the ninth position but this was the
least stable of all of the pyrazole nucleoside strands. All four of the pyrazole nucleosides
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had a ATm range similar to that of 5-nitroindoIe (10-15 “C) but the overall change in Tm
firom the controls was greater for the pyrazole nucleosides than for 5-nitroindole.
The results firom the incorporation into the Brown sequence show that the
stabili^ trend seen in the Dickerson sequence is continued. In this case there was the
possibility to incorporate only one modified nucleoside in each duplex which lessened
the amount of destabilization. 5-Nitroindole dropped the Tm 5 degrees and the pyrazole
nucleosides lowered it about 7 degrees. Because a single modified nucleoside can easily
be compensated for by the duplex the difference in stability of the nucleosides is not as
obvious. Therefore a strand was also made that incorporated three modifications.
These TmS showed more variation and surprisingly the nitropyrazole nucleoside was
more stable than the propynepyrazole (Table 4.2).
4.7 Discussion
The stability of the pyrazole nucleosides followed the order predicted by electronic and
steric considerations. Himter et

studied the importance of the issue of

electrostatics in base stacking and found that it plays a role comparable with sterics in
establishing the sequence dependent secondary structure of DNA. Base stacking occurs
most favorably when there is the ability to compensate for centers of negative charge on
one base with centers of positive charge on the base with which it is stacking. A
beautiful display of this is the helix itself which occurs because of the need to offset
bases that are stacking to minimize negative interactions. The four natural nucleosides
have charge distribution patterns that concentrate negative charges in different positions
on the bases vdiich allows beneficial overlap when the bases are arranged in the
classical double helix. Nucleosides that have little or no charge distribution may not be
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Table 4.2. Thermodynamic results of melting studies on the modified noncomplementary strands.
AG

Tm

AH

(®C at 15 pmol )

(kcal/mol)

C ontrol (C )

5 9 .1

-1 4 0 .4

-4 2 7 .9

-1 2 .9

N 1

5 1 .2

-7 6 .5

-2 4 1 .1

-4 .6

P i

6 0 .8

-8 8 .2

-2 6 9 .4

-7 .9

T1

6 0 .6

-1 2 1 .7

-3 7 0 .1

-1 1 .4

D 1

5 4 .5

-1 2 0 .4

-3 7 3 .0

-9 .3

N 3

3 3 .6

-9 1 .6

-3 0 4 .0

-1 .0

P3

3 0 .1

-9 4 .6

-3 1 7 .2

-0 .0

AS

(cal/K*moi) (kcal/mol at 2!
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as good at accommodating the partial atomic charges of the natural nucleosides. The
electronic charge profiles of the pyrazole bases indicate that the base with the most
charge localization is thiazolepyrazole followed by propynepyrazole and nitopyrazole.
In addition the increasing size of the nitropyrazole, propynylpyrazole and
thiazolepyrazole would suggest that the stability would increase in that order. Modeling
studies (using Huckel molecular orbital calculations in Sybyl molecular modeling
program) show that the bases stick into the major groove which allows the increasing
size to overlap more with the base on their 5' side and increase stability. A crystal
structure of the toluated propynepyrazole (Figure 4.8) and iodopyrazole (Figure 4.9)
nucleosides a torsion angle of ~ 80®C for 0-CT-N1-N2. This puts the substituents on
the edge of the major groove and allows maximum base stacking possibilities without
introducing steric considerations. A second configuration could have been possible by
steric interactions, the substituent sticking more directly into the major groove however
that would have more limited stacking possibilities. While non-hydrogen bonding
nucleosides cannot overcome the loss of energy fiom hydrogen bonds to solvent that are
broken, the choice of a base with an ^propriate electronic charge distribution can
greatly increase the stability over an abasic site or a non-polarizable substituent such as
the phenyl ring. Kool and cowodcers^^ showed that pairing non-hydrogen bonding
nucleoside can also increase the stability because there is no need to break hydrogen
bonds, however, their structures were not exceptionally stable possibly in part because
the structures are relatively unpolarizable (although diflourotoluene does have partial
atomic charges that may be the same as T but much smaller) and may encounter some
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Figure 4.8 Crystal structure of tolulated propynepyrazole nucleoside.
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Figure 4.9 Crystal Structure of Tolulated iodopyrazole nucleoside.
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of the same problems as the phenyl ring, which is not polarizable enough to stabilize a
duplex wellJ4*17 ^ ig therefore obvious that there are many considerations when
designing a nucleoside analog not the least of which should be the electronic structure
of the base.
4.8 Experimental
4.8.1 l-{2*-Deaxy-3',5*-Bis-^p-toluoyi-P-D-ribofaranosyl)-4-nitropyrazole (2c).
4-Nitropyrazole (2.769 g, 24.3 nunol) was dried and then dissolved in dry
acetonitrile (20 mL) imder Ar. It was added dropwise to a solution of NaH (0.62 g, 25.8
nunol) in dry acetonitrile (10 mL). at 0®C. It was stirred at room temperature imtil clear
and then an additional 30 minutes. 3,5-Bis-O-p-toluoyl-l-chloro-P-D-ribose was added
(11.94 g, 30.7 mmol) and the solution was stirred under Ar. for 3 hows. The solution
was filtered and the filtrate was washed with CH3CN. The solution was concentrated
under reduced pressure and purified by silica column (CHCI3) to yield 12.24 g (86 %) of
a white solid. m.p. 154® C; TLC: Rr=0.50 (1:2 EtOAc-Hexanes) HRMS FAB (MNBA)
Theoretical: 466.1614 (M +H)\ Found: 466.1606 (M+H)^. ‘H (200 MHz, CDCI3) 5 8.36
(s, IH, H-5), 8.06 (s,lH, H-3), 7.94 (d, Jat=8.2, 2H, Ar), 7.88 (d, Jat=8.3, 2H, Ar), 7.27
(d, Jat=8.1, 2H, Ar), 7.22 (d, Jat=8.3, 2H, Ar), 6.20 (app.t, Jh2-=6 .0, 1H, HI"), 5.77 (app.
dt, Jh2-=32, Jh4-=6 .3 , 1H, H3*), 4.70-4.63 (m, 2H, H4' & H5"), 4.54 (dd, Jh 4-=6 .2 ,
Jh5-=13.5, 1H, H5"), 3.22 (app. dt, J=6.2, Jh2-=14.2, 1H, H2'), 2.85 (ddd, Jh 3 -= 4 .0 ,
Jhi-=6.4, Jh2-=14.4, IH, H2"), 2.44,2.41 (s, 3H, CHj-Ar).

(50 MHz, CDCI3) 166.10,

165.80 (C(O)-Ar), 144.48, 144.11 (C(O)-Ar), 136.22 (C5), 129.65,129.56, 129.16,
129.06, (Ar), 127.86, (C3), 126.58, 126.33 (Ar-CHs), 105.00 (C4), 90.66 (CIO, 83.60
(C40,74.56 (€30,63.61 (€50,37.80 (€20,21.60,21.55 (Ar-CHa).
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4.8^ l-(2'-Deoxy-P-D-ribofunuio^l)-4-iiitropyrazole (3c).
l-(2'-Deoxy-3’,5'-Bis-0-p-toluoyl-P-D-ribofuranosyl)-4-nitropyrazole (1.65 g,
3.55 mmol) was suspended in methanol (100 mL) and then 100 mL of ammonia
saturated methanol was added. The solution was stirred for 24 hours, and then
concentrated under reduced pressure. It was purified by silica column (4:5
CHzClz/EtOAc) to give a yeUowish oU (0.717g, 88%). TLC: Rf=0.17 (1:2 CH2CI2EtOAc) . HRMS FAB (MNBA) Theoretical: 230.0776 (M+H)\ Found: 230.0756
(M+H)+. ‘H NMR (200 MHz, CD3OD) 5 8.76 (s, IH, H5), 8.12 (s, IH, HI), 6.14 (app.
t, Jh2-=6 .4 , IH, HIO, 4.50 (app. dd, Jh 2*=5 .5 , Jh4-=10.5 , IH, H3"), 4.02 (app. dd, Jh 5^ - 3 ,
Jh3-=8.7, IH, H4’), 3.75 (dd, Jh4-=3.7, Jhs^I 1.9, IH, H5"), 3.64 (dd, Jh4-=5.17, Jh5-=12.0,

IH, H5'), 2.84-2.71 (m, IH, H2*), 2.52 (ddd, Jh3-=L7, Jhi-=7.1, Jh2-=13.9, IH, H2).
(250 NMR, CD3OD) Ô 137.01 (C5), 130.01 (C3), 92.15 (Cl*), 89.70 (C4’), 72.17 (C3'),
63.35 (C53,41.44 (C2").
4.83 l-(2'-Deoxy-5’-dimethoxytrityl-P-D-ribofuraiiosyl)-4-nitropyrazole (4c).
l-(2'-Deoxy-P-D-ribofuranosyl)-4-nitropyrazole (0.717g, 3.13 mmol) was co
evaporated with pyridine three times (1 mL) and then dissolved in dry pyridine(15 mL)
and DIEA (10 mL) under Ar. DMT-Cl (1.08 g, 3.18 mmol) and DMAP (0.38 g, 3.11
mmol) were dried and added to the solution. It was stirred for 24 hours. Water (250
mL) was added and the product extracted with ether (3 x 100 mL). The combined ether
layers were washed with NaHCOs, and brine then dried with Na2S04 and concentrated
under reduced pressure. It was purified by alumina column (20:1 EtOAc-CHgOH) to
give 1.47 g (88%) of oU. TLC: Rf = 0.18 (4:3:1 Hexanes-EtOAc-EtsN) FAB MS (NBA)
531.4 (M+H)+ IH (250 MHz, CDCI3) 6 8.33 (s, IH, H5), 8.01 (s, IH, H3), 7.38 (app. d.
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J=7.6,2H, Ar), 7.30-7.14 (m, 7H, Ar), 6.80 (app. d, J=8.7,4H, Ar), 6.04 ( app. t,
Jm-5.7, IH, HI"), 4.57 (app. dd, J=5.6, J=10.5, IH, H3"), 4.19 (app. dd, J=4.4, J=8.8,
IH, H4"), 3.74 (s, 6H, OMe), 3.30-3.22 (m, 2H, H5’ & H5"), 2.79-2.69 (m, IH, HZ'),
2.57-2.43 (m, IH, H2"). ‘^C (300 MHz, C

D 3O D ) Ô

160.12 (Ar-OMe), 146.38 (C5),

137.25,137.17 (Ar-C), 136.96 (C3), 131.35, 129.99, 129.38, 128.83, 127.87 (Ar),
114.15 (C4), 91.98 (Cl*), 88.35 (C4"), 87.62 (C-Ar), 72.43 (C3'), 65.21 (C5"), 55.79
(OMe), 40.91 (C2").
4.8.4 l-(2*-Deoxy-5*-dimethoigrtrityl-3'-0-2-cyanoethyl-N,Ndiisopropylphosphoniiiiidite-P-D-riboliDnuiosyl)-4-nitropynizoIe (5c).
l-(2'-Deoxy-5*-dimethoxytrityI-p-D-ribofviranosyl)-4-mtropyrazole (0.52g, 0.98
mmol) was twice co-evaporated with pyridine. It was then dissolved in CH2CI2 (5 mL)
and triethylamine (0.75 mL) under Ar. The diisopropylchlorocyanoethyl
phosphoramidite (0.3 mL, 1.3 mmol) was added slowly and it was stirred for 15
minutes. It was quenched with methanol and then washed with brine. It was dried with
Na2S04 and concentrated under reduced pressure. It was purified by alumina column
(2:1 Hexanes/EtOAc) to give a white foam (0.6224g, 87%). TLC: R f = 0.70 (4:3:1
Hexanes-EtOAc-EtsN). HRMS FAB Theoretical: 732.3161 (M+H)^. Found: 732.3153
(M+H)^. ^‘P mixture o f diasteromers (101.2 MHz, CDCI3) 5 147.81, 147.63. *H
mixture of diasteromers (250 MHz, CDCI3) S 8.37, 8.35 (s, IH, H5), 8.04 (s, IH, H3),
7.39-7.36 (m, 2H, Ar), 7.29-7.20 (m, 7H, Ar), 6.82-6.78 (m, 4H, Ar), 6.08 (dd, Jh2-=5 .8 ,
Jh2-=8.7 , IH, HI"), 4.68 (m, IH, H4"), 4.28 (app. t, J=4.2, IH, H3"), 3.78 (s, 6H, OMe),

3.70-3.52 (m, 4H, CH3-CH and O-CH2), 3.26 (dd, J=7.4, J=14.3,2H, H5’and H5"),
2.84-2.56 (m, 4H, C2 and CH2-CN), 1.26-1.08 (m, 12H, CH3-CH).
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4.8^ l-(2'-Deoxy-3'^'-Bis-0-p-tolaoyl-p-D-ribofiiranosyI)-4-iodopynizole (2a).
4-Iodopyrazole (6.481 g, 33.4 mmol) was dried and then dissolved in dry
acetonitrile (30 mL) under Ar. It was added dropwise to a solution of NaH (1.01 g,
42.09 mmol) in dry acetonitrile (20 mL). at 0®C. It was stirred at room temperature until
clear and then an additional 30 minutes. 3, 5-Bis-O-p-toluoyl-l -chloro-P-D-ribose was
added (13.01 g, 33.7 mmol) and the solution was stirred under Ar. for 3 hours. The
solution was filtered and the filtrate was washed with CH3CN. The solution was
concentrated under reduced pressure and purified by silica column (3:2 CH2CI2Hecanes) to yield 13.26 g (72 %) o f a white solid. m.p. 110 °C. TLC: Rf= 0.66 (1:2
EtOAc-Hexanes). FABMS (Glycerol) 547.3 (M+H)^; ‘H (250 MHz, CDCI3), 7.94 (d,
J at= 4 . 1 ,

1 H ,

Ar), 7.91 (d, J

at=

4 .2 ,

IH, Ar), 7.64 (s, IH, H5), 7.54 (s, IH, H3), 7.27 (d,

J at= 2 . 9 ,

IH, Ar), 7.22 (d, J

at=

7 .8 ,

IH, Ar), 620 (t, Jh2=6.2, IH, HI*), 5.75 (dd, J=2.8,

J=5.9, IH, H3’), 4.63-4.49 (m, 3H, H4 and H5), 3.20-3.09 (m, IH, H2'), 2.66 (ddd,
J=3.7,6.2,9.8, IH, H2"), 2.42 (s, 3H, CH3), 2.41 (s, 3H, CH3).

(75 MHz, CDCI3) S,

166.17 (C(0)), 165.82 (C(0)), 145.23 (C5), 144.26 (C(O)-Ar), 143.82 (C(O)-Ar),
133.19 (C3), 129.66 (Ar), 129.11 (Ar), 126.83 (Ar-CH3), 126.55 (Ar-CH3), 89.84 (Cl*),
82.84 (C4"), 75.06 (C3*), 64.03 (C5"), 37.41 (C20,21.66 (CH3). Anal. Calcd for
C24H23IN2O5: C 52.76, H 4.24, N 5.13. Found: C 52.57, H 4.50, N 5.11.
4.8.6 l-(2'-Deoxy-p-D-ribolaranosyl>-4-iodopyrazole (3a).
l-(2'-Deoxy-3',5'-Bis-G-p-toluoyl-P-D-ribofuranosyI)-4-iodopyrazoIe (2.08 g,
3.8 mmol) was suspended in methanol (100 mL) and then 100 mL of ammonia saturated
methanol was added. The solution was stirred for 24 hours, and then concentrated
under reduced pressure. It was purified by silica colunm (4:5 CHzClz/EtOAc) to give a
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yeUowish oü (1.013 g, 86%). TLC: Rf=0.39 (9:1 CHCI3-CH3OH). FABMS (Glycerol)
311.3 (M+H)"^. ‘H (250 MHz, CDCI3) ô 7.60 (s, IH, H5), 7.59 (s, IH, H3), 6.11 (t,
J h 2 = 6 .4 ,

IH, Hl*), 4.74 (dd, J=2.7,5.6, IH, H3"), 4.13 (app. d, J=2.4, IH, H4’), 3.88 (dd,

J h 4 - = 2 .0 , J h 5 - = 1 2 .6 ,

IH, H5*), 3.72 (dd, Jm-=2.0, J

h

5 ^ 1 2 .6 ,

1 H ,

H5"), 2.89-2.78 (m, IH,

H2’), 2.41 (ddd, J=3.1, J=6.8, J=13.8, IH, H2'). "C (62.5 MHz, CDCI3) 5 145.78 (C5),
134.11 (C3), 89.92 (Cl*), 89.04 (C4*), 72.72 (C3"), 63.36 (C5"), 41.64 (C2"). Anal. Calcd
for C»H,|N203: C 30.99, H 3.58, N 9.03. Found: C 30.75, H 3.80, N 9.05.
4.8.7 l-(2'-Deoxy-5'-dimethoxytrityl-P-0-ribofnranosyi)*4-iodopyrazole (4a).
1-(2-Deoxy-P-D-ribofuranosyl)-4-iodopyrazole (0.9991g, 3.23 mmol) was coevaporated with pyridine three times (1 mL) and then dissolved in 10 mL of dry
pyridine and 8 mL of DIEA under Ar. DMT-Cl (1.05 g, 3.09 mmol) and DMAP
(0.4245 g, 3.47 mmol) were dried and added to the solution. It was stirred for 24 hours.
250 mL of water was added and the product extracted with ether (3 x 100 mL). The
combined ether layers were washed with NaHCOg, and brine then dried with NaiSO#
and concentrated under reduced pressure. It was purified by alumina column (4:3:1
Hexanes-EtOAc-Et3N) to give 1.45 g (73%) of oil. m.p. = 35®C. TLC: Rf==0.34 (4:3:1
Hexanes-EtOAc-Et3N). FABMS (NBA) 612.6 (M+H)^. ‘H (200 MHz, CDC13) 5 7.64
(s, IH, H5), 7.46 (s, IH, H3), 7.40 (app. d, J=8.0,2H, Ar), 7.24-7.16 (m, 7H, Ar), 6.80
(app. d, J=8.2,4H, Ar), 6.09 ( app. t, Jh2-=5.1, IH, HI"), 4.62-4.57 (m, IH, H3"), 4.19
(app. dd, J=4.2, J=8.8, IH, H4'), 3.78 (s, 6H, OMe), 3.34-3.17 (m, 2H, H5' & H5"),
2.79-2.67 (m, IH, H2"), 2.57-2.438 (m, IH, H2"). Anal. Calcd for C29H29IN2OS: C
56.87, H 4.77, N 4.57. Found: C 56.71, H 4.89, N 4.61.
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4.8.8 l-(2*-Deoxy-5'-dimethoxytrityl-3*-0-2-^anoethyI-N^diisopropylphosphonumdite-p-D-rii}ofanuiosyl)-4-iodop3rrazole (5a).
l-(2'-Deoxy-5'-<Iimethoxytrityl-P-D-ribofuranosyI)-4-iodopyrazole (0.39g, 0.64
mmol) was twice co-evapoiated with pyridine. It was then dissolved in CH2CI2 (5 mL)
and triethylamine (0.4 mL) under Ar. The diisopropyichlorocyanoethylphosphoramidite
(0.15 mL, 1.05 mmol) was added slowly and it was stirred for 1 hour. It was quenched
with water and then washed with brine. It was dried with Na2S04 and concentrated
under reduced pressure. It was purified by alumina column (2:1 Hexanes/EtOAc) to
give a white foam (0.366 g, 71 %). TLC: Rf=0.35 (4:3:1 Hexanes-EtOAc-EtsN). HRMS
FAB (MNBA) Theoretical: 812.2159 (M). Found: 813.2262 (M+H)^

(101.2

MHz, CDCI3) mixture of diasteromers Ô 147.62,147.35. 'H mixture o f diasteromers
(250 MHz, CDCI3) 8 8.23 (s, IH, H5), 7.68 (s, IH, H3), 7.42-7.39 (m, 2H, Ar), 7.317.19 (m, 7H, Ar), 6.82-6.78 (m, 4H, Ar), 6.05 (app. t,

J h 2-= 5 .9 ,

IH, HI"), 4.69-4.63 (m,

IH, H4*), 4.20-4.16 (m, IH, H3'), 3.78 (s, 6H, OMe), 3.66-3.48 (m, 4H, CH3-CH and OCHz), 3.24-3.21 (m, 2H, H5"), 2.78-2.40 (m, 4H, C2 and CH2-CN), 199 (s, 3H,
CH3),1.32-1.12(m, 12H, CH3-CH).
4.8.9 1-(2'-Deoxy-3',5'-Bis-0-/^toluoyl-P-D-ribofurano^l)-4-propynyIpyrazole
(2d).
l-(2'-Deoxy-3',5'-Bis-0-^toluoyl-P-D-ribofuranosyl)-4-iodopyrazole (7.1 g, 13
mmol) was introduced into a 280 mL pressure reactor. DMF (70 mL) and triethylamine
(15 mL, 107.6 mmol) were added and the solution was purged with Ar and sonicated (3
times). The flask was cooled to -78°C and 14 mL of propyne (247.17 mmol) was
condensed. Copper iodide (0.5011 g, 2.63 mmol) and Fd(GAc)2(Fh3P-resin) (0.801
mmol) w ae added and the flask was sealed and warmed to room temperature. It was
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stirred for 24 hours. The solvents were removed under reduced pressure and the product
was purified by silica column (DCM) to give 5.75 g of a white solid (96 %). m.p. TLC:
Rf=0.22 (3:1 Ether-Hexanes). FABMS (glycerol) 459.1 (M+H)^. ‘H (250 MHz,
CDCh) Ô7.93 (d, J/vr=7.9,4H, Ar), 7.65 (s, IH, H5), 7.57 (s, IH, H3), 7.27 (d, J
2H, Ar), 7.21 (d, J
J h 4 - = 6 .4 ,

at

= 7 .7 ,

2H, Ar), 6.16 (t, J

h

2 - = 6 .1 ,

IH, HI*), 5.76 (app. dd, J

h

at=

2 .4 ,

2 - = 3 .2 ,

IH, H3'), 4.60-4.48 (m, 3H, H4' and H5’), 3.21-3.11 (m, IH, H2), 2.66 (ddd,

J h i= 6 .6 , J h 3 = 3 .7 , J h 2 = 1 4 .4 ,

IH, H2’), 2.42 (s, 3H, Ar-CHj), 2.40 (s, 3H, Ar-CHj), 1.99

(s, 3H, C-CH3). ‘^C (50 MHz, CDCI3) Ô 166.25 (C(0)), 165.87 (C(0)), 144.26 (C(0)Ar), 143.78 (C(O)-Ar), 142.75 (C5), 131.10 (C3), 129.78 (Ar), 129.22 (Ar), 129.12
(Ar), 129.02 (Ar), 126.98 (Ar-CHs), 126.67 (Ar-CHs), 104.83 (C4), 89.78 (Cl*), 86.52

(Pyrazole-C), 82.74 (C4% 75.21 (C3'), 70.24 (C-CH3), 64.21 (C5"), 37.35 (C7), 21.69
(Ar-CHa), 4.27 (C-CH3). Anal. Calc’d for C27H26N2O5: C70.73, H 5.72, N 6.11. Found:

C 70.56, H 5.71, N 5.92
4.8.10 l-(2'-Deoxy-p-D-ribofaranosyI)-4-propynylpyrazole (3d).
l-(2'-Deoxy-3’,5’-Bis-0-p-toluoyl-P-D-ribofi]ranosyl)-4-propynylpyrazoIe (1.0 g,
2.18 mmol) was suspended in methanol (100 mL) and then K

2 C O 3

(5.1g) was added.

The solution was stirred for 18 hours, and then the potassium carbonate was filtered and
the solvent removed under reduced pressure. It was purified by silica column (1:2
CH2Cl2/EtOAc) to give a yellowish oU.(0.41 g, 85%). TLC: Rf=0.24 (9:1 CHCI3CH3OH). 'H (250 MHz, CDCI3) 8 7.60 (s, IH, H5), 7.56 (s, IH, H3), 6.00 (t, Jh2=6.2,
IH, HI"), 5.09 (app. d, J=5.4, IH, H3*), 4.04 (app. d, J=2.3, IH, H4% 3.81-3.77 (m, IH,
H5"), 3.69-3.61 (m, IH, H5"), 2.74-2.63 (m, IH, HZ'), 2.32 (ddd, J=1.5, J=5.8, J=13.0,
IH, HZ'), 1.96 (s, 3H, CH3). ‘^C (62.5 MHz, CDCI3) 5 143.00 (C5), 131.68 (C3),
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104.04 (C4), 89.79 (Cl% 88.87 (C4% 86.69 (pyrazoIe-C), 72.44 (C3*), 69.76 (C-CHj),
63.25 (C5"), 41.50 (C2% 4.15 (C-CH3).
4.8.11 l-(2'-Deoxy-5'-dimethoxytrityl-P-D-ribofaranosyI)-4-propynylpynizole (4d).
l-(2'-Deoxy-P-D-ribofuranosyl)-4-propynyIpyrazole (0.41 g, 1.8 mmol) was co
evaporated with pyridine three times (5 mL) and then dissolved in 15 mL of dry
pyridine and 6 mL of DEEA under Ar. DMT-Cl (.9387 g, 2.77 mmol) and DMAP
(0.3378 g, 2.76 mmol) were dried and added to the solution. It was stirred for 48 hours.
250 mL of water was added and the product extracted with ether (3 x 100 mL). The
combined ether layers were washed with NaHCOs, and brine then dried with NazSO#
and concentrated under reduced pressure. It was purified by alumina column (4:3:1
Hexanes-EtOAc-EtsN) to give 0.7568 g (83%) of oil. TLC: Rf=0.54 (4:3:1 HexanesEtOAc-EtaN). ‘H (200 MHz, CDCI3) S 7.54 (s, IH, H5), 7.41 (s, IH, H3), 7.34-7.31
(m, 2H, DMT), 7.23-7.07 (m, 7H, DMT), 6.75-6.69 (m, 4H, DMT), 5.93 (dd, J h2-=4.6,
J h2-=6.6,

IH, HI"), 4.50 (dd, J=5.8, J=10.9, IH, H3'), 3.92 (dd, J=5.1, J=10.I, IH, H40,

3.71 (s, 6H, OCH3), 3.27-3.09 (m, 2H, H5"), 2.73-2.61 (m, 2H, H2*), 1.91 (s, 3H, CH3).
'^C (50 MHz, CDCI3) 6 158.48 (Ar-OCH3), 149.10,144.67 (DMT), 142.24 (C5),
135.84 (C3), 130.73, 130.02, 128.13, 127.82, 126.76,113.14 (DMT), 104.39 (C4),
8924 (Cl'), 86.40 (C-(Ar)3), 85.63 (Pyrazole-C), 85.63 (C4"), 72.37 (C3'), 70.42 (CCH3), 64.06 (C5'), 55.15 (OCH3), 39.73 (C2), 4.21 (C-CHj).
4.8.12 l-(2'-Deoxy-5'-dimetfaoiQtrityl-3'-0-2-^anoethyl-N,Ndiisopropylphosphorainidite-P-D-riboliiranosyi)-4-propynylp3rnizole(Sd).
l-(2'-Deoxy-5'-dimethoxytrityl-P-D-ribofuranosyl)-4-propynylpyrazole (1.0936
g, 222 mmol) was twice co-evaporated with pyridine. It was then dissolved in CH2CI2
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(5 mL) and triethylamine (1.5 mL) under Ar. The diisopropyichlorocyanoethyl
phosphoramidite (0.3 mL, 1.34 mmol) was added slowly and it was stirred for 1 hour. It
was quenched with methanol and then washed with brine. It was dried with NazS04 and
concentrated under reduced pressure. It was purified by alumina column (2:1
Hexanes/EtOAc) to give a white foam (1.315 g, 89 %). TLC: Rf= 0.56 (4:3:1 HexanesEtOAc-EtsN). HRMS FAB (MNBA) Theoretical: 724.3389 (M). Found: 725.3427
(M+H)^

(101.2 MHz, CDCI3) mixture of diasteromers ô 155.28,155.01. 'H

nuxture of diasteromers (250 MHz, CDCI3) 8 7.67 (s, IH, H5), 7.50 (s, IH, H3), 7.437.40 (m, 2H, Ar), 7.31-7.19 (m, 7H, Ar), 6.82-6.78 (m, 4H, Ar), 6.05 (app. t, Jh2-=5.9,
IH, HI*), 4.69-4.63 (m, IH, H4*), 4.20-4.16 (m, IH, H3"), 3.78 (s, 6H, OMe), 3.66-3.48
(m, 4H, CH3-CH and O-CH2), 3.24-3.21 (m, 2H, H5"), 2.78-2.40 (m, 4H, C2 and CHzCN), 1.99 (s, 3H, CH3),1.32-1.12 (m, 12H, CH3-CH).
4.8.13 Synthesis and Characterization of OUgodeoxyribonucIeotides.
OUgodeoxyribonucleotides were prepared from commercially available dA, dC,

d o , dT (Applied Biosystems division of Peridn Elmer) and d(5-nitroindole) (Glen
Research) on an ABI synthesizer using standard solid phase phosphorantidite chemistry
(l|iM scale). Stepwise coupling yields ranged from 80 to 100 %. The 5'-trityl protected
oligonucleotides were removed firom the CPG and deprotected by treatment with
concentrated NH3 at 55°C for 8 hours. The oligonucleotides were purified using
Oligopurification Cartridges from ABD-Perkin-Elmer according to the manufacture's
instructions. The purified oligomers were evaporated to dryness using a centrifuge
ev^wrator and stored at -5®C. The purity was detemtined by reverse-phase HPLC
(Waters 486 equipt with a Supelco LC-18S SUPELCOSIL C18 (4.9x250 mm) column
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using 95% IM triethylammonium acetate (TEAA) and 5% .05M (TEAA) 4:1 CH3CNH2O initial conditions going to 75% IM triethylammoniinn acetate (TEAA) and 25%
.05M (TEAA) 4:1 CH3CN-H2O) and they were characterized by MALDI mass
spectrometry.
4.8.14 Thermal Dénaturation Studies
Solvent Preparation. An estimate o f the amount of oligonucleotide needed was
determined by UV(260 nm) (Gilford) in H2Oand then the sample was evaporated to
dryness using a centrifuge evaporator. The samples were dissolved in a pH 7 buffer of
4x(1.0 M NaCU 10 mM sodium phosphate, and 0.1 mM EDTA) and diluted fourfold.
Where necessary serial dilutions were made. All solvents were degassed in a vacuum
desiccator prior to use. The concentration was determined using the assumption that at
high temperature the oligonucleotides are unstacked and unpaired. The absorbance was
determined at 80°C and Beer's Law (A=ecl) was used to determine the concentration
utilizing an estimate of the extinction coefficients as calculated below.
Calculation o f extinction coefficient estimates. The extinction coefficient
(5.818,0.101,0.127) of each of the unprotected modified nucleosides (nitro, iodo,
propynyl and thiazoyl) was determined by making a Beer’s Law plot o f the absorbance
(260 nm) at each of 5 known concentrations. The extinction coefficient of 5-nitroindole
was supplied from Donald Bergstrom (15.296). The absorbance of the intact
oligonucleotide was measured (260 nm in a Tris sodium phosphate buffer) and then the
oligonucleotide was digested with snake venom phosphodiesterase. The absorbance
was read for the solution that then contained the completely unbound nucleosides. A
ratio was developed between the two to account for the hypochromicity. The summation
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Table 4 3 : Maldi results

Calculated

MALDI Results

X-Y

IM-Hl

fM-HT

Control-A

3680

3675

Control-C

3656

3657

Control-G

3696

3697

Control-T

3671

3670

5-nitroindole-A

3712

3715

5-mtroindoIe-C

3688

3689

5-nitroindole-G

3728

3725

5-nitroindole-T

3703

3706

4-iodopyrazoIe-A

3632

3634

4-iodopyrazole-C

3608

3605

4-iodopyrazoIe-G

3648

3649

4-iodopyrazole-T

3633

3632

4-propynylpyrazole-A

3623

3620

4-propynyIpyrazole-C

3599

3601

4-propynylpyrazole-G

3639

3641

4-propynylpyrazole-T

3614

3614

4-thiazolylpyrazole-A

3669

3671

4-thiazolylpyrazoIe-C

3645

3644

4-thiazolyIpyrazole-G

3682

3684

4-thiazolylpyrazole-T

3660

3662

Complementary Strand

5135

5136

Control

5242

5246

4-nitropyrazole-1

5244

5245

4-propynylpyrazoIe-l

5237

5232

4-nitropyrazoIe-3

5218

5215

4-propynyIpyrazoIe-3

5197

5197
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o f the mononucleotides are made and then multiplied by the hypochromicity factor to
determine the extinction coefBcients. For the self-complemantary strands, the nearest
neighbor estimate of each of the four control sequences was determined using the
method and values from Gratzer and Richards.^^ The sum of the extinction o f the
mononucleotides was also determined and a ratio of nearest neighbor to sum o f
mononucleotides was made.^^ The sum of the individual mononucleotides
(incorporating the calculated extinction coefficients of the modified nucleotides) was
calculated for the modified strands and these were multiplied by the ratio to account for
nearest neighbor effects.
UV melting measurements. Absorbance versus temperature profiles were determined at
260 nm on a Gilford spectrometer equipped with a Peltier temperature controlling
device and thermal software. The average of 3-5 absorbance readings was determined
at 5®C and/or 25®C before and after each melt to determine that evaporation was less
than 5%. Nitrogen was run through measurement chamber to prevent condensation.
Prior to measurement all samples were heated to 95®C for 2 min to drive the equilibrium
to duplex. They were then cooled to 5®C and equilibrated for 5 minutes. One
concentration for each duplex was determined in both a heating and cooling ramp to
ensure that the duplex behaved the same way. Then 4-5 concentrations (covering 100fold concentration difference) were run in a heating run at I°C/min utilizing pathlenghts
of 0.01 cm to 1 cm. For each of the concentrations a curve was generated that related
absorbance to temperature called a melting curve. Equation 4.1 was developed by
Gralla and Crothers^^ for the analysis of melting curves. It corresponds to the
derivative of the melting curves.
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Table 4.4 Extinction coefBcients

Sequence

Hypochomicity Factor

Extinction coefficeint
(mmor*«cm*‘)

Control GC

110.7

Control AT

112.5

Control TA

115.1

Control CG

109.7

Nitro A

0.892

112.50

Nitro C

0.894

105.59

Nitro G

0.886

108.28

Nitro T

0.872

104.13

lodo A

0.892

107.40

lodo C

0.894

100.49

lodo G

0.886

103.22

lodo T

0.872

99.15

PropyneA

0.892

107.42

Propyne C

0.894

100.50

Propyne G

0.886

103.24

Propyne T

0.872

99.16

Complementary Strand

0.868

147.5

Control Strand

0.819

162.3

Nitro 1

0.807

158.6

Nitro 3

0.804

153.4

Propyne 1

0.737

140.6

Propyne 3

0.682

118.6

Indole 1

0.770

158.7

Indole 3

0.734

160.97

Thiazole 1

0.834

164.8

Thiazole 3

0.808

156.9
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ôa

a(l à)/SH

L ^ i/n J

(\-^ a )R

-

Equation 4.1. Equation for the derivative of a melting curve.
Derivative of Melting Curve

0.12

0.08

0.4

0.6

alpha value»

Figure 4.10 Graph of the derivative with values of alpha of 0—>^1.
At the m aximum of the derivative curve a=0.414 as shown by the graph o f the
derivative using values of alpha corresponding to 0—>1 (Figure 4.10). In addition the
second derivative of the melting curve is equal to zero at the inflection point (Tmax of

âa

0 .1 7 2 A J ^

R
Equation 4.2. Derivative of melting curve at T »., (o=0.414)
the derivative curve) of the melting curve (this also defines cc=0.414 at Tmax). If you
plug the value a=0.414 back into Equation 4.1 then you get Equation 4.2. However the
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melting temperatuieCTm) is defined as the temperature when there is an equal number of
strand that are in a duplex as there are single stranded or when oc=0.5. When a=0.5 is
plugged into Equation 4.1, Equation 4.3 results. Therefore to calculate Tm (o=0.5)

0.167 A//

da

R
Equation 4 3 . Derivative curve when ce= 0 3 .
from Tmax (o=0.414) Equation 4.4 is used. However Equation 4.4 can be simplified to

da
_ 0.167
0.172 _^1/T_x)_
U i/r .) J
da

Equation 4.4. Ratio to calculate Tm from Tmax
multiplying Tmax by 0.971 to obtain Tm- A plot o f l / T m (in Kelvin) versus In(C) was
made using the 4-5 concentrations as shown in Figure 4.11. From the slope and

Graph ofl/Tm versus Ln(C)
0.003
y =-3B0Sx +0.0031

0.00298 -

*=09965

0.00296
E 0.00294
^ 0.00292
0.0029
0.00288
0.00286
2

3

4

5

6

7

Ln(C)

Figure 4.11 Graph of 1/Tm versus Ln(C) using various concentrations.
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Table 4.5 Slope, intercept and fit of 1/Tg, versus Ln(C) for oligonucleotides
Rvalue

Slope

Intercept

Number of

(-1x10'*)

(1x10'^

samples

Control GC

2.1

3.07

8

0.995

Control AT

2.4

3.13

5

0.997

Control TA

2.6

3.19

4

0.995

Control CG

2.7

3.13

4

0.998

5-nitroindole-A

8.1

3.55

3

0.851

5-nitroindole-C

4.9

3.41

3

0.994

5-nitroindole-G

5.8

3.48

3

0.999

5-nitroindole-T

4.0

3.35

3

0.999

Nitro A

4.0

3.51

4

0.986

Nitro C

5.3

3.66

6

0.988

Nitro G

6.0

3.69

4

0.989

Nitro T

5.3

3.62

4

0.996

lodo A

7.0

3.71

6

0.991

lodo C

5.9

3.78

5

0.998

lodo G

6.7

3.75

5

0.999

lodoT

6.3

3.76

4

0.935

Propyne A

4.8

3.52

7

0.973

PropyneC

6.8

3.78

5

0.988

Propyne G

3.7

3.53

4

0.990

Propyne T

9.4

3.79

4

0.999

Control Strand

1.4

3.05

3

0.989

Nitro 1

2.6

3.15

3

0.989

Nitro 3

2.2

3.32

3

0.993

Propyne 1

2.3

3.06

3

0.76

Propyne3

2.1

3.35

2

1.00

Indole 1

1.6

3.10

2

1.00

Sequence
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intercept of the line the thermocfynamics could be determined. The values of the slope,
intercept and fît are given in Table 4.5. The thermodynamic parameters were calculated
using equations 4.5-4.7.38

A H = -^
Slope
Equation 4.5. Equation used to calculate AH.

AS = A /f X intercept
Equation 4.6. Equation used to calculate AS.

AG = AH-TxAS
Equation 4.7. Equation used to calculate AG.
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Chapter 5
Pofymerase Chain Reaction

The polymerase chain reaction (PCR) is a process used to amplify DNA. It
utilizes a pair of synthetic primers flanking the region of a template that needs to be
amplified (with their 3’ends facing each other) where each is complementary to a
different DNA strand and an enzyme that extends the primer oligonucleotide according
to the template to which it is complementaryJ Initially the Klenow fragment of E.coli
was used as the extension en^rme, however the dénaturation step (which is required to
separate the complementary template strands) inactivated the enzyme which proved to
be costly and tedious. Therefore the reaction did not enjoy a great deal of success until
the discovery of the Thermus aquaticus (Taq polymerase) enzyme in the geysers of
Yellowstone National Park.2 This enzyme was useful under a much greater range of
temperature conditions than prior enzymes which allowed the reaction to work more
reliably and with greater specificity for a wide range of compounds.^ In addition the
Taq polymerase does not contain a 3-5' proofreading exonuclease activity which means
the enzyme can not remove the trailing nucleotides in an attempt to "correct" the
sequence.^ This prevents the nucleosides from being removed once they were inserted
but also meant there was no mechanism for correction if a nucleoside was inserted
incorrectly (meaning it was not the natural complement to that space on the template).
This allows the process to create some mistakes or mismatches at a rate which can be
cause for concern. Additionally the process suffers from cross-contamination (a
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consequence of its extreme sensitivity) and the limitation on the size that can be
amplified (above about 1 kb the efficiency declines). However these problems are being
addressed.^
5.1 Applications of PCR
PCR has been used for a variety of applications. The most obvious is for the
production of large amounts o f oligonucleotides. In addition it as been used in the
determination of the preference of nucleotides for the natural nucleotides and to
determine the relative stability o f modified nucleotides. It could also be used to detect
point mutations in DNA.
5.1.1 Amplification of DNA
The amplification of DNA is the most straightforward application of the
polymerase chain reaction. It has been applied to the analysis of DNA fix>m mummies,
forensic purposes, amplification of viruses in experimental medicine, diagnosis of
genetic diseases and a variety of other applications.^ In this reaction the DNA that
needs to be amplified is called the template. Both strands of a double stranded helix are
generally amplified although this is not necessary. However if only one strand is
amplified the rate of amplification is much slower, increasing only by the amount of the
template each round. If both strands are amplified the rate of amplification is
exponential and can result in the amplification of DNA by a million times or more in
25-45 cycles. In addition to the template there must be a supply of primers for any
sequence that is going to be amplified. The primer must be complementary to the
section of the template corresponding to the beginning of the desired oligonucleotide at
the 5' end. Therefore if only one strand of the double stranded helix is going to be
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amplified the template must be the complement to the desired product. The reaction
also uses a supply o f ATP-nucleosides.
The components are introduced to the reaction and it is initially heated to
^xproximately 95°C for about a minute to denature the double helix. The reaction
mixture is then cooled to 35**C to allow the primers and templates to anneal. This is
promoted by the use of a large excess of primer (usually 100 fold or more depending on
the amount of amplification needed). The extension reaction is effected at a
temperature of 50-55®C for several minutes. This allows the enzyme to coordinate with
the primer-template duplex and to extend the oligonucleotide with the ATP nucleosides.
The reaction mixture is then denatured and the daughter strands are used as templates as
well as the original templates. Therefore the product increases exponentially. A
diagram of this process is shown in Figure 5.1.
5.1.2 Determination of Preference for Natural Nucleotides
PCR can be used as a tool to aid in the determination of the preference for the
natural nucleotides by modified nucleotides. It can provide added depth to the
information provided by thermal melting studies. In general the modified nucleosides
are incorporated into an oligonucleotide and subjected to a PCR reaction.7,8,9 in
addition the modified nucleotides can be converted to ATP nucleosides and used as the
building blocks in the extension of a normal primer. When the modified nucleoside is
in the primer the goal is to determine the ratios o f the four normal nucleosides that are
incorporated into the primer strand versus the modified spot in the template This gives
the preferred nucleoside that is "written" against a modified nucleoside. When the
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Figure 5.1 The pofymerase chain reaction.
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nucleoside is converted to an ATP nucleoside and used in PCR the goal is to determine
the nucleoside that the modified nucleoside prefers to "read".
The reaction utilizing modified nucleosides follows the same procedure as in a
normal PCR reaction but incorporates the modified nucleosides into the primer or
nucleoside supply. However the reaction conditions may have to be modified slightly to
account for the difference in the stability of the duplex and the ability of the enzyme to
complex the modified duplex. Potentially the PCR reaction may not proceed at all in
the presence of a modification either because the duplex is not stable enough or because
the ability of the enzyme to bind to the duplex has been severely hampered.
5.13 Determination of Relative Stability of Nucleosides
This approach has recently been used by Kool and co-workers^® based on the
prior work of Goodman and co-workers. ^^ Strictly speaking these reactions generally
are not chain reactions in that they do not occur in repetitive loops that greatly amplify
the product. They are generally conducted in one loop and the rate of incorporation of a
single extension to the primer is. In this process the modified nucleotide is incorporated
into the template of interest and the rate of extension was observed. This can be used to
make comparisons on the stability of various modified nucleosides. The incorporation
of each of the four nucleosides is incorporated individually against the modified
nucleoside and the rate is measured. The fastest rate corresponds to the most stable pair.
However it should be cautioned that the rate of extension is dependent not only on the
stability of the duplex (which is a direct result of the stability imparted by the
nucleoside) but also on the likelihood of the entyme to bind to the duplex and allow
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extension. In order to get an accurate rate based on the modified nucleoside only, the
binding constant must be taken into account.
5.1.4 Use of PCR to Detect Point Mutation
PCR in conjunction with modified nucleoside can be used to detect point
mutations in DNA. This is accomplished by "converting" a nucleoside in the normal
strand into a restriction endonuclease site. The point mutation does not get converted in
the process. This process takes advantage of the fact that some modified nucleoside
prefer to "read" and "write" different natural nucleosides. With a group of nucleosides
designed to cover each possible desired conversion (16 possibilities) the conversion
could just mean the appropriate choice o f modified nucleoside. Both strands get
amplified and then when subjected to a restriction endonuclease the normal strands are
eliminated and the "mutant" strands can be detected. In this process it must be noted
that PCR does create mutations at a rate o f 1 in 10^-10^12,13 which could effect results
if not accounted for or corrected.
SJL Target of the PCR Experiments
The results we hope to obtain fix>m PCR was to determine if the modified
nucleosides can function in a PCR reaction and to assess their potential as "convertides"
or nucleosides that effect the change o f a single nucleotide in DNA to aid in the
detection of point mutations. Therefore the series of pyrazole nucleoside 1-(4iodopyrazole)-2-deoxy-P-D-ribosenucleoside (Figure 5.2, A), 1-(4-nitropyrazole)-2deoxy-p-D-ribosenucleoside (Figure 5.2, B), 1-(4-propynepyrazole)-2-deoxy-P-Dribosenucleoside (Figure 5.2, C), l-(4-(2-thiazoyly)pyrazole)-2-deoxy-p-Dribosenucleoside (Figure 5 2, D) (and 5-nitronindoIe as a control) were incorporated
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Figure 5.2 Modified nucleosides used in PCR studies
into a primer 40-mer oligonucleotide. The basic procedure for the Polymerase chain
reaction was provided by Dr. Geoff Hoops.

The sense strand 40-mer primer was

designed to correspond to the positions -10 to 30 of the E. coli hisF gene in the
expression vector phisF-tac (Figure 5.3). The antisense primer was a 30-mer that
corresponded to positions 757 to +10 as shown in Figure 5.3. The Ms F gene is shown
in capital letters. The sense strand is shown on the top and the antisense strand on the
bottom. The sequence o f the template that was used for the primers is underlined. The
position of the variable base in the sense strand is indicated by a trailing asterisk. The
natural base is an G. Thus in the first round the primer and the antisense primers attach
to their respective templates creating new strands that were shortened on the end closest
to where th^r attached. The next round could have the primer and antisense primer
attach to the original template or the slightly shortened sequences. If they attach to the
original template then they would again create sequences slightly shortened on one end.
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Figure 5.3 Sequence of the target PCR product, the A6F gene.
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If the primer or antisense primer attach to the newly made shortened sequence then the
extension reaction will create a strand shortened on each end, which is the target of the
PCR reaction. This procedure was demonstrated in Figure 5.1. This group is the
dominant product of the PCR because of the nature of the exponential increase. The PCR

therefore created an 797 mer complementary to the hisF gene region of the template even
though the template was much longer.
5 3 Procedure
The antisense primer and the primer A ^ch contained the modified nucleoside
were synthesized according to procedures outlined in Chapter 4. They were added to the
template {phisF-tac plasmid cleaved with a restriction enzyme), the en^m e (Amplitaq
fiom Perkin-Elmer) and all four of the natural dNTPs. The product was then obtained by
PCR as described above. There are two groups that do not accurately show the
nucleoside that is incorporated versus the modified nucleoside and they must be removed
prior to analysis of the sample. These are the original template strands and the sequences
that were created slightly shortened on one end. This is accomplished by purification
with electrophoresis using an agarose/urea gel. By comparison with “ladders” o f known
length the band for the target product can be identified and excised. The product is then
extracted fix>m the gel using a crush and soak technique. The purified target nucleoside is
then sequenced to determine which base (or the percentages o f each base if more than one
is incorporated) is incorporated. This is accomplished by setting up four reactions where
each one uses a different dideoxynucleotide. The target oligonucleotide and a primer for
the strand of interest is put into each of the four reactions along with the necessary
enzyme. After the reaction is complete the strands are purified by electrophoresis
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Figure 5.4 Agarose gel separation of the target oligonucleotide after PCR.
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usû% an aciylamide gel and the sequence can be determined. In this example the strand
we sequence is the sense strand therefore the base that is shown in the variable position is
the one that was incorporated against the base that was dictated by the modified base in
the antisense strand. For example if sequencing shows a G in the variable position the
base that was inserted opposite the modified base was a C.
5.4 Results and Discussion
Initially the PCR reactions yielded no result The salt content and concentrations
were varied and fi-esh enzyme was used. Eventually the problem was traced to the
template. It had to be cut with a restriction enzyme prior to PCR. Once this was
accomplished using the PVU2 restriction enzyme the PCR reaction worked well. All of
the modified nucleosides (including 5-nitroindole) and the control strand were subjected
to PCR in triplicate simultaneously. They were all then purified by agarose gel as can be
seen in Figure 5.4. All of the reactions produced a product in the desired range except for
two of the 5-nitroindole strands. These are evident by the bright spot in each of the lanes
at the point that corresponds to ^proximately 800 base pairs in the pGem and
Lambda/ECORI HindTTT markers that were used for comparison. One of each of the
control, 5-nitropyrazole and 5-propynepyrazole were then sequenced. The results of the
sequencing can be seen in Figure 5.5. Reading from bottom to top (the longer strands are
closer to the top) the sequence can be picked out as 5*-AAAACGCATAATCCCATGT in
the region of interest for all three of the strands. This would indicate that the two
modified strands had incorporated a C. This is the correct pattern for the control however
abasic modified nucleosides tend to incorporate a n

Therefore we were skeptical

of the results. This skepticism was augmented by the presence of “shadow”
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Figure S£ Sequencing results of the target oligonucleotide.
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bands underneath each o f the true bands. Shadow bands are caused by impure primers in
the initial or sequencing reactions. They are equivalent to a strand that terminates in the
same base but is one base shorter in length. The shadow bands were eliminated by
further purification of the primer that was used in the sequencing reaction. The
incorporation of the C the modified base still occurred. This was most likely due to
impure primers used in the original PCR reactions. If the primers were not long enough
to contain the modified base then the PCR reaction would amplify the strands in the same
manner as the control. This was shown to be the case when the reaction was repeated
with purified primers. ^^ With purified primers the base incorporated versus the modified
nucleosides was an A. Therefore the modified nucleosides were shown to function in
PCR and incorporate an A as is expected for abasic sites.
5^ Experimental
All oligonucleotides were provided by Midland Certified Reagent Company. The
enzyme and accompanying buffers were finm Perkin-Elmer (trade name Amplitaq). The
dNTPs were ^^P labeled and acquired fix>mAmersham.
5^.1 Digestion of the Expression Vector ^hisF-tac
The expression vector phisF-tac was digested with the PVU2 restriction enzyme
from New England Biolabs. The total reaction volume was 50 pL for Ipg of plasmid and
1 pL of enzyme. It was digested at room temperature for 30 minutes and used unpurified.
5^^ Polymerase Chain Reaction
The basic procedure for the Polymerase chain reaction was provided by Dr. Geoff
Hoops.

The following conditions were used to amplify the template DNA containing

the hisF%ea&'. lOOpL reactions buffered to 100 mM Tris (pH 7.8), 50 mMKCl, 10 pg/mL
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gelatin, 1.5 mM MgC12, ~ 100 pmol sense-strand primer, ~ 100 pmol antisense-strand
primer, finol quantities of template DNA and 2.5 units of Amplitaq. The reactions were
run in 500 pL microcentrifuge tubes topped with 75 pL of mineral oil. The samples were
equilibrated at 95®C for 5min and then were subjected to 31 PCR thermal cycles. The
cycles consisted of a denature step at 95°C for 1 minute followed by an annealing step at
37®C for 1 minute and then an extension step at 70®C for 5 minutes. At the end there is a
10 minute extension at 70°C.
5.5.3 Purification of PCR Product
The product of the PCR reaction was purified by electrophoresis using an agarose
gel. The gel was 1.2% agarose in a standard TAE buffer (Tris/acetate/EDTA). The gel is
heated until it boiled and then poured into the horizontal plate and the combs added.
After solidification the samples are loaded using a load buffer composed of Ficoll 400,
NazEDTA, sodium dodecylsulfate, bromophenyl blue and xylene cyanol. The samples
are then run in a TAE buffer at 75-100 volts. The commercially available markers
Lambda/ECORI-Hindin and pGem (purchased from Promega) were run with the samples
and were used to determine the position of the target oligonucleotide. When the run was
complete the gel was stained using an ethidium bromide solution and the product band
was carefully excised. The product was extracted from the agarose gel using the
Geneclean kit fi-om Bio 101 according to manufacturer’s directions.
5.5.4 Sequencing of PCR product
The PCR product was sequenced using the Thermosequenase Kit from
Amersham. This kit employs the T7 Sequenase enzyme and all four [a-33P] labeled
dideoxnucleotide (ddNTP) terminator nucleotides. This ensures that only the properly
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terminated nucleotides are labeled which eliminates background bands. Four reactions
are set up simultaneously where each corresponds to one of either A, C, G or T
dideoxynucleosides. The kit was used according to manufacturer’s direction. The
antisense strand was used as the template. Therefore a primer corresponding to the sense
strand was used in the reaction. The reaction was cycled 30-35 times and used an
annealing temperature of 57^C which differs from manufacturer’s directions. Each o f the
four reaction products was “run” in a separate lane using electrophoresis on a
polyacrylamide gel. The gel was a 10% acrylamide gel that was 19:1 acrylamide to
bisacrylamide. The gel contains urea and is in a standard TBE buffer (Tris/boric
acid/EDTA). The samples were run at - 85 watts. The gels were imaged and the bands
quantified using phosphorimaging on the Storm® system. The percent incorporation of
each natural nucleoside could be determined by extending a horizontal line across the row
corresponding to the modified nucleoside (background strands were subtracted) using
molecular analyst software. The area of the peak corresponding to each of the four lane
was calculate to determine the percentage incorporation of each nucleoside.
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Chapter 6
Conclusions

The purpose of this project was to design, synthesize and incorporate several
modified nucleosides into oligonucleotides. The nucleosides were 5-(2'-deoxy-|3-Dribofuranosyl)-2-hydroxypyrimidine (Figure 6.1, A) and a series of 4-substitiuted
pyrazole nucleosides including l-(2'-deoxy-P-D-ribofuranosyl)-4-iodopyrazole (Figure
6.1, B), l-(2'-deoxy-P-D-ribofiiranosyl)-4-nitropyrazole (Figure 6.1, C), l-(2'-deoxy-PD-ribofiiranosyl)-4-propynylpyrazole (Figure 6.1, D), and l-(2'-deoxy-P-Dribofuranosyl)-4-(2-thiazolyl)pyrazole (Figure 6.1, E). The purpose of the research was
twofold. By generating these nucleosides we hoped to find information about the role
of base stacking in the stability of the DNA duplex and determine if the appropriate
choice of nucleosides could be used as “conversion agents” or in ambiguous positions in
probes and primers. Therefore the nucleosides were synthesized and tested for stability
in a duplex by thermal melting and in PCR reactions. In addition 1-(2'-deoxy-P-Dribofuranosyl)-2-hydroxypyriinidine is a C-nucleoside which is of interest in its own
right because of the potential for anti-viral and anti-cancer properties. The pyrazole
series of nucleosides were designed to illuminate the differences charge distribution,
polarizability, and size in the absence of hydrogen bonding have on base stacking in the
double helix.
Synthesis of the C-nucleoside 5-(2’-deoxy-P-D-ribofuranosyl)-2hydroxypyrimidine was hampered by a number of synthetic hurdles such as starting
114
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materials that were difBcult to prepare and were often stable for only short periods of
time. In addition both the Pd coupling procedure and the Grignard procedure yielded
reaction mixtures that were a complex mixture of numerous products. Traces of the
desired product was occasionally seen but was never isolated. Therefore 5-{2'-deoxy-PD-ribofûranosyl)-2-hydroxypyrimidine is unlikely to be generated by a coupling
procedure that unites a pre-formed sugar system to a base however it is being
investigated by the method of construction of the base on the sugar.
One of the starting materials needed for the synthesis of 5-(2'-deoxy-P-Dribofuranosyl)-2-hydroxypyrimidine was a protected furanoid glycal. Therefore an
investigation of the synthesis of furanoid glycals was conducted. Using a method
introduced by Pedersen’s, we were able to prepared furanoid glycals having both O-silyl
and, for the first time, 5-O-acyl protection. The advantages of this method were found
to be the ability to use a greater generality of protecting groups and increased speed and
experimental ease with which glycals could be made. Glycals made herein under
Pedersen conditions, including four previously unknown glycals, had yields that were
comparable to yields achieved by previous methods, but had fewer steps.
The synthesis o f the pyrazole series of nucleosides (Figure 6.1, b-e) were
successfully synthesized and incorporated into oligonucleotides. The thermodynamic
properties were then determined by thermal melting. The thermodynamic results
indicate that the series of pyrazole nucleosides shows a relative increase in
thermodynamic stability (based on increasing Tm) as the substituents vary fix>m iodo to
nitro and propyne to thiazole which followed the order predicted by electronic and steric
considerations. For iodo and propyne the preference was for A over G when pairing
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with the natural nucleosides but thiazole pyrazole showed a preference for G over A and
nitropyrazole showed a preference for A then T. It is unlikely that the results are based
on sequence alone because the control sequence with A in the ninth position (the
position across fiom the modified nucleoside) was the least stable. While non-hydrogen
bonding nucleosides cannot overcome the energy lost when hydrogen bonds to solvent
are broken, the choice o f a base with an appropriate electronic charge distribution can
greatly increase the stability over an abasic site or a non-polarizable substituent such as
the phenyl ring.
In order to determine whether modified nucleoside can fimction as “conversion
agents” they must be shown to function in PCR reactions. The pyrazole series of
nucleosides (Figure 6.1, b-e) were incorporated into primers and utilized in PCR
reactions. All of the reactions were able to produced a product which showed the were
capable of performing in a PCR reaction primer. Initially the natural nucleoside
incorporated versus all o f the 4-substituted pyrazole nucleosides was a C. This is the
correct pattern for incorporation versus the control however abasic modified nucleosides
tend to incorporate an A which caused some skepticism of the results. This was
discovered to be due to impure primers used in the original PCR reactions. When the
primers were further purified the sole nucleoside incorporated versus the modified
nucleosides was an A which is more consistent with literature findings.
Overall the 4-substituted pyrazole nucleosides were successfully synthesized and
incorporated into oligonucleotides. They were able to function effectively in both
thermodynamic studies and PCR reactions. The results of both studies proved
consistent with expectations based on literature precedence.
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Appendix A
Table o f Abbreviations

a

ratio of strands in the duplex state to total number of strands

ATP

adenosine triphosphate

CIMS

chemical ionization mass spectrometry

COSY

correlated spectroscopy 2D NMR

CFG

controlled pore glass

DEPT

distortionless enhancement by polarization transfer ID NMR

dA

deoxyadenosine

dC

deoxycytidine

ddNTP
DIBAL-H

any of the four natural (A, C, G or T) nucleosides as a
dideoxynucleoside
diisobutylaluminum hydride

DIEA

diisopropylethylamine

dO

deoxyguanine

DMAP

dimethylaminopyridine

DMF

dimethylformamide

DMT

dimethoxytrityl

DNA

deoxyribose nucleic acid

dNTP

any of the four natural deoxy nucleosides (dA, dC, dG or dT)

dT

deoxythymidine

DPPP

bis(diphenylphosphino)propane

FABMS

fast atom bombardment mass spectroscopy
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HETCOR

heteroscalar correlation 2D NMR

HMDS

1,1,1333-hexamethyldisilazane

PCR

polymerase chain reaction

Taq

Thermits aquaticus polymerase

TBDMS(-Ci)

r-butyldimethylsilyl(chloride)

TBDPS(-Cl)

r-butyldiphenylsilyl(chloride)

TCA

trichloroacetic acid

THF

tetrahydrofnran

Tm

TMS

melting temperature-temperature (at a specific concentration
and buffer condition) where half the DNA is in the duplex and
half is in the single stranded state,
trimethylsilyl

ToI(-CI)

p-toluoyl(-chloride)
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